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DETERMINANTS AND MECHANISMS OF SMOKING CESSATION: 
SECONDARY OUTCOMES ANALYSES OF A COMMUNITY SMOKING 
INTERVENTION IN BOSTON PUBLIC HOUSING  
JOANNA LEE BURTNER 
Boston University School of Public Health, 2017 
Major Professor: Daniel R. Brooks, DSc, Associate Professor of Epidemiology 
ABSTRACT 
Cigarette smoking is the leading cause of preventable morbidity and 
mortality in the United States.  While smoking rates have steadily declined 
among the general population, smoking is becoming increasingly concentrated 
among socioeconomically disadvantaged groups due to higher initiation and 
lower cessation rates.  This dissertation examines determinants and mechanisms 
of smoking cessation in the context of the Kick it for Good study (KIG), a 
community smoking intervention for Boston public housing residents.  
In the first study, we explored mediators and moderators of the KIG 
intervention effect on smoking cessation.  We did not find any significant 
mediators for 3-mo cessation outcomes, although there was modest evidence for 
mediation by self-efficacy to quit at 12-months.  We found living with other 
smokers and perceived stress were moderators of the KIG intervention effect on 
smoking cessation.   
In the second study, we examined predictors of attitudes and knowledge 
of nicotine replacement therapy (aNRT).  We found discussing smoking 
 x 
cessation with a healthcare provider and use of nicotine replacement therapy 
(NRT) were associated with more positive attitudes and greater knowledge of 
NRT.  The KIG intervention did not impact aNRT outcomes throughout the study 
period. 
In the third study, we examined the effect of depression on smoking 
cessation and whether this effect was moderated by social support.  We found 
smokers with depression classified by the 10-item Center for Epidemiologic 
Studies Depression Scale (CES-D-10) were more likely to report smoking 
abstinence than those without depression.  Social support did not moderate the 
effect of depression on cessation.  We also conducted a sensitivity analysis to 
determine if the cutoff of 10 for the CES-D was valid in this population of low-
income and racially/ethnically diverse smokers.  We did not find evidence of 
depression misclassification by the CES-D-10, although there remains the need 
to validate the scale in socioeconomically disadvantaged populations.     
These findings provide valuable information on how smokers living in 
Boston public housing were able to achieve smoking abstinence in the context of 
a cessation intervention.  The insights gained from these results may be applied 
to future intervention studies to help address the disparity in smoking rates 
among socioeconomically disadvantaged smokers.   
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 1 
INTRODUCTION 
 
Cigarette smoking is the leading cause of preventable disease and 
mortality in the United States, accounting for more than 480,000 deaths every 
year1.  While current smoking has declined from 21% of adults in 2005 to 15% in 
2015, the rate among persons living below the poverty level is 29%2.   
Smoking prevalence is becoming increasingly concentrated among 
individuals who are socioeconomically disadvantaged because of higher rates in 
smoking initiation and lower rates of cessation in this population3,4.  Smoking 
cessation interventions have been shown to help smokers quit, and clinical 
practice guidelines recommend a combination of counseling and medication, 
such as nicotine replacement therapy (NRT)5.  However, outcomes are poorer 
among racial/ethnic minorities and those of low socioeconomic status (SES) 
resulting in lower quit rates among these groups6–8.  Still, a high proportion of 
individuals of minority race/ethnicity are interested in quitting smoking and willing 
to participate in cessation interventions9. 
The Kick it for Good (KIG) study leveraged the unique characteristics of 
the public housing environment to focus on increasing smoking cessation rates 
among public housing residents.  There is a high concentration of low-income 
and racially/ethnically diverse smokers in public housing10.  Thus, a cessation 
intervention in this population would address the disparity in cessation rates 
among socioeconomically disadvantaged smokers.  Also, the use of community 
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health workers (CHW’s) is cost-effective, improves disease management, and 
increases health knowledge11–13.  A smoking cessation intervention that uses 
CHW’s to deliver the intervention could work well in a public housing setting.  The 
KIG study utilized tobacco treatment advocates (TTAs) who were public housing 
residents trained in motivational interviewing (MI) to deliver the cessation 
intervention.  TTAs provided counseling to study participants to increase 
utilization of cessation services such as telephone quit lines and clinic-based 
cessation programs.  The aims of the KIG study were to increase utilization of 
cessation services and increase smoking abstinence rates in a population of 
Boston public housing residents.  
To give context to the dissertation studies that utilize data from KIG, we 
present a brief overview of the relevant methods and results of the KIG study.  
KIG was a cluster-randomized intervention trial among smokers at 26 Boston 
public housing sites. Inclusion criteria for participants in the study were ages 18–
79, smoked ≥100 cigarettes in lifetime, current smoker, planning to quit smoking 
in 30 days or thinking about quitting in next 6 months, speak English or Spanish, 
and plan to live in public housing for the next 12 months. Exclusion criteria 
included abstinence from tobacco for ≥7 days, current use of pharmacological 
treatment for smoking cessation, currently engaged with the Smokers Quitline or 
other clinic-based cessation program, and cognitive/ psychiatric conditions that 
would interfere with the ability to participate in the study. Enrolled smokers were 
randomized based on their public housing site into the intervention group or the 
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control group.  The study was approved by the Boston University Medical Center 
Institutional Review Board. 
The intervention (TTA-MI) focused on using motivational interviewing (MI) 
to motivate smoking cessation and to connect participants with community 
resources for quitting smoking (e.g., the Quitline and smoking cessation group 
treatment), and learn about pharmacological options for quitting.  The TTA also 
helped participants to connect to the resources for quitting smoking (e.g., 
contacting the quit line together or setting up a quit line appointment, planning 
transportation to their doctor; finding low-cost or no-cost options for nicotine 
replacement) and facilitate appointments (e.g., find a primary care doctor, find 
local health centers that offer smoking cessation). The TTA met with each 
participant in their home, up to nine times.  The first visit was 30–45 minutes and 
subsequent visits were 20–30 minutes.  Visits used MI communication skills 
(open-ended questions, reflections, summaries) and strategies (e.g., ‘Typical 
day’, pros and cons of quitting, collaborative decision making, eliciting self-
motivational statements, exploring confidence and motivation to quit) to discuss 
the following topic areas:  risks of continuing to smoke, building confidence to 
quit smoking, concerns about gaining weight, curbing your cravings, managing 
stress and mood, quitting for good, and second hand smoke.  To facilitate 
collaborative agenda setting, participants were allowed to pick whichever topic 
they wanted to discuss.  However, social support (positive and negative) was 
discussed at visit 2 with all participants, since this was hypothesized to be 
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integral to the population based on formative research 14–16.  Each topic area 
included a visually appealing handout.  The intervention content and MI 
strategies were based on a previous study17,18.   
Once participants were motivated to quit, they completed a written quit 
plan in which they set a quit date, identified smoking triggers and coping 
strategies, identified steps to procure pharmacological treatment for cessation, 
and identified people to help support their attempt.  At this point, the TTA 
switched focus to motivating the participant to call the quit line or connect with 
community resources, and participants were given the choice if they wanted to 
continue to meet with the TTA (for up to nine sessions total) or discontinue and 
solely utilize the community resources.    
Participants at control sites (TTA-SC) received standard stop-smoking 
materials and a single session of approximately 45 minutes with an English-
Spanish bilingual control TTA. The control TTA provided basic smoking cessation 
information, including benefits of quitting, importance of support, medication and 
counseling options, and strategies to prevent relapse. For those participants 
ready to make a quit attempt, the control TTA helped develop a quit plan. 
A total of 506 smokers were recruited and 331 (65%) were enrolled.  
Participants had to have at least one visit with their TTA to be considered 
enrolled.  Among those enrolled, 73% completed the 3-month follow-up survey, 
76% completed the 7-month follow-up survey, and 76% completed the 12-month 
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follow-up survey.  There were a variety of survey completion patterns as 
participants were allowed to be captured at intermittent follow-up periods.  
However, 48% of participants completed the 3-month, 7-month, and 12-month 
follow-up surveys (Figure 1).  At each follow-up, participants completed a survey 
which asked about their use of cessation services such as the telephone quit line 
or local clinic-based program and their use of medication to quit smoking 
including nicotine replacement therapy and other pharmacotherapy aids.  
Participants’ general health and psychosocial functioning were also assessed.  
Abstinence was self-reported as not smoking for the past 7-days and the past 30-
days.  Participants who reported not smoking for the past seven days were 
administered a carbon monoxide (CO) breath test.  Exhaled CO of less than or 
equal to 8 parts per million was used to biochemically verify past 7-day 
abstinence19. 
Results showed that the TTA intervention was successful in helping 
participants achieve abstinence.  Among those who completed the 3-month 
follow-up, n=15 (13.6%) of TTA-MI participants were biochemically verified to be 
abstinent from smoking in the past 7 days while n=9 (6.8%) were abstinent in the 
TTA-SC group.  In unadjusted analyses, those assigned to TTA intervention were 
more likely to be abstinent from smoking for both the past 7 days (OR = 1.60, 
95% CI 0.77 – 3.32) and the past 30 days at 3-month follow-up (OR = 2.25, 95% 
CI 1.01 – 5.03).  Adjustment was made for potential confounders by using a 
propensity score which included race, enrollment time, health, depression, 
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nicotine dependence, age, gender, cigarettes per day, lifetime quit attempts, 
previous NRT use, motivation to quit, and self-efficacy to quit in the model.  After 
adjusting for the propensity score as a covariate, intervention effects were 
attenuated, but remained similar for both 7-day PPA (OR = 1.37, 95% CI 0.68 – 
2.76) and 30-day PPA (OR = 1.89, 95% CI 0.85 – 4.20).   
Among those who completed the 12-month follow-up, n=18 (14.9%) of 
TTA-MI participants were biochemically verified to be abstinent from cigarettes in 
the past 7 days while n=10 (7.8%) were abstinent in the TTA-SC group.  
Unadjusted analyses showed TTA intervention participants were more likely to 
be abstinent from smoking for the past 7 days (OR = 1.90, 95% CI 1.35 – 2.68) 
and the past 30 days (OR = 2.29, 95% CI 1.29 – 4.04) at 12-month follow-up.  
After adjusting for propensity score, a similar intervention effect was observed for 
both 7-day PPA (OR = 2.60, 95% CI 1.72 – 3.94) and 30-day PPA (OR = 2.98, 
95% CI 1.56 – 5.68).   
In sum, the Kick it for Good intervention utilized tobacco treatment 
advocates trained in motivational interviewing techniques to increase both 
motivation to quit smoking and utilization of quit smoking resources among 
socioeconomically disadvantaged smokers.  The intervention effects on 
cessation were seen during the active intervention period at 3-month follow-up 
and after the intervention period ended at 12-month follow-up.  Increasing 
abstinence among public housing residents through the use of a community 
health worker intervention is a notable achievement given the increased barriers 
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to quitting smoking and the negative health effects of sustained smoking in this 
high-risk, hard-to-reach population. 
This dissertation examines secondary outcomes of the KIG study to 
further understand the determinants and mechanisms of smoking cessation 
among Boston public housing residents.  First, we explored mediators and 
moderators of the effect of the KIG intervention on smoking cessation.  
Understanding the pathways via which the intervention operates and the 
subgroups for whom the intervention has the greatest effect can inform future 
intervention studies that utilize community health workers in socioeconomically 
disadvantaged populations.  Furthermore, previous mediation analyses that have 
examined smoking cessation outcomes have relied on methods outlined by 
Baron and Kenney20.  Our mediation analyses utilizes a novel counterfactual 
approach21 which allows for the decomposition of the direct and indirect effect of 
the intervention on cessation.  The second study explored predictors of positive 
attitude towards nicotine replacement therapy.  Among racial and ethnic 
minorities, there is mistrust and misinformation22,23 about nicotine replacement 
therapy despite its clinical benefit for cessation5.  Positive attitudes toward the 
use of pharmacotherapies are associated with smoking cessation24,25; thus, 
understanding how we can enhance attitudes and beliefs may inform how we 
approach the topic of increasing NRT use in this population.   Finally, we 
examined the effect of depression on smoking cessation.  Depression is known 
to be associated with negative smoking outcomes26,27, although these effects are 
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shown to be buffered by social support15.  The incidence of depression is higher 
among socioeconomically disadvantaged populations such as public housing28, 
although public housing residents may experience increased social support due 
to the close geographical proximity of their community29.  Moreover, the KIG 
intervention directly increased social support through contact with the TTAs.  Due 
to the variable factors among public housing residents that may differentially 
affect cessation, we examined the direct effect of depression on cessation and 
seek to determine if this effect is moderated by social support.  These results will 
inform whether depressed smokers living in public housing should receive a 
more or less intensive intervention and how we might harness the social 
structure of the public housing community and a CHW-based intervention to 
increase smoking cessation. 
This dissertation contributes to the literature on smoking among 
socioeconomically disadvantaged populations by using epidemiologically 
advanced methods to generate a greater degree of insight into determinants and 
mechanisms of cessation among Boston public housing residents.  The results 
are intended to be clinically relevant and inform future interventions that aim to 
reduce the health disparities arising from smoking among public housing 
residents.   
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Figure 1. Survey completion patterns of enrolled KIG participants 
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MEDIATORS AND MODERATORS OF PAST 30-DAY SMOKING 
ABSTINENCE IN THE KICK IT FOR GOOD STUDY 
BACKGROUND 
 
There are many smoking cessation interventions proven to help smokers 
quit30–32.  Clinical practice guidelines suggest a range from individual, group, and 
telephone counseling to the use of seven first-line medications (5 nicotine and 2 
non-nicotine)5.  Furthermore, quitline counseling is shown to be effective among 
diverse populations33,34.  The Kick it for Good intervention utilized many of these 
evidence-based practices to encourage smokers to quit.  While analyses have 
shown that the intervention increased overall quit rates in the TTA-MI group 
compared to TTA-SC, it is of clinical significance to determine how public 
housing smokers quit and contributing factors to successful abstinence.  
Examining mediators and moderators of successful cessation may help identify 
which components of the TTA intervention increases smoking cessation and 
provides insight on which sub-populations may benefit the most.  These findings 
can thus support dissemination and implementation efforts.  This is especially 
salient since these questions have yet to be explored in a socioeconomically 
disadvantaged population. 
Hypothesized potential mediators of the KIG intervention include utilization 
of the Massachusetts Quitline or local clinic-based programs, NRT use, 
motivation to quit, and self-efficacy to quit.  The use of quit lines, local clinic-
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based programs, and NRT are intended mediators of the intervention as TTAs 
encouraged participants to use these evidence-based methods to quit5.  
Increasing motivation to quit and self-efficacy to quit were also targets of the TTA 
intervention as they have been shown to predict smoking cessation35–37.   
Furthermore, the Transtheoretical Model, a health behavior change theory, 
proposes that motivation to quit and self-efficacy to quit should predict intention 
to quit, quit attempts, and smoking cessation38.  Thus, motivation to quit and self-
efficacy to quit were assessed as potential mediators of the intervention effect on 
smoking abstinence.   
It is unknown whether the hypothesized mediators are part of the indirect 
effect of the KIG intervention.  Other studies of cessation interventions that have 
examined potential mediators using mediational analyses have shown that 
increases in self-efficacy, changes in smoking temptations, and partner support 
contribute to cessation39–41.  However, these mediation analyses and others have 
relied on product methods, originally outlined by Baron and Kenny20.  This 
approach was the standard in epidemiology until the advent of a method rooted 
in the counterfactual framework published in 2013 by Valeri and Vanderweele21.  
The utility of the counterfactual method over the product method is its ability to 
break down the total effect of the exposure on outcome into direct and indirect 
effects even in models where interactions and nonlinearities occur.  When it is of 
interest to assess whether the effect is mediated by a specific pathway or other 
hypothesized mediators, the decomposition of the total effect into separate direct 
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and indirect effects is useful.  The current study utilizes this approach to examine 
mediation in the context of the KIG intervention.    
Finally, there are factors, some especially relevant to socioeconomically 
disadvantaged populations that may moderate the KIG intervention effect, 
including gender, age, ethnicity, nicotine dependence, presence of other 
smokers, perceived stress, and social support.  Younger age34 and Black or 
Hispanic race/ethnicity42,43 are associated with reduced likelihood of cessation.  
Women are less likely to respond to nicotine replacement therapy and have 
lower quit rates compared to men44,45.  Poor psychosocial functioning, including 
depressed mood and high levels of perceived stress, are also associated with 
poor cessation outcomes46–48.  Certain smoking characteristics, such as high 
nicotine dependence and the presence of other smokers in the household, may 
reduce the likelihood of successful cessation49–51.  Social support is known to be 
associated with increased probability of quitting smoking, particularly among low-
income and ethnically diverse populations14,15,34,52.  These variables were chosen 
for their known associations with smoking cessation, although they have yet to 
be investigated as potential moderators in the context of a smoking cessation 
intervention for public housing residents.  Additionally, moderation analyses have 
generally been assessed using methods of interaction term significance, 
stratification, or comparison of group-specific estimates34.  We compared the 
potential differing effects of the KIG intervention among sub-groups by using 
methods based on biological interactions53. 
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The aim of this study was to assess the mechanisms through which the 
KIG intervention effects occur (mediators) and identify the groups for whom the 
intervention has the greatest effect (moderators) on smoking cessation.  We 
hypothesize the intervention will directly affect hypothesized mediators: Quitline 
or local clinic program use, NRT use, motivation to quit, and self-efficacy to quit.  
The mediators will in turn affect 30-day point prevalence abstinence at 3-month 
and 12-month follow-up.  Gender, age, ethnicity, nicotine dependence level, 
presence of other smokers, stress, and social support will moderate the effect of 
the intervention on 30-day point prevalence abstinence at follow-up.  Specifically, 
the greatest effects of the intervention will be observed among those who are 
young, White, male, have lower nicotine dependence, do not live with other 
smokers, report lower stress, and have higher social support.   
METHODS 
Design 
The design of this study was a randomized control trial since the exposure 
variable of interest, the KIG intervention, was randomized at baseline.  
Participants were followed-up over time and outcomes were assessed at 3-
months, 7-months, and 12-months after baseline.   
Participants 
The analytic sample was composed of participants who were enrolled at 
baseline and had at least one visit with their TTA (n=331).  Analyses were 
conducted for the 3-month and 12-month follow-up among participants who 
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completed the relevant follow-up.  Multiple imputation was also used to account 
for loss to follow-up at 3 and 12-months.   
Covariate Measures 
Covariates included age (18–39 vs. 40+), sex (Female vs. Male), race 
(White, Black, Hispanic), cigarettes per day (≤10 vs. 11+), Fagerstrom Test for 
Nicotine Dependence (FTND) score (≤4 vs. 5+)54, lifetime quit attempts (0, 1, 2+), 
previous NRT use, health status (excellent/very good vs. good/fair/poor), 
depression (dichotomized based on CESD-10 score)55, and enrollment time into 
the study (3/31/2012 or earlier, 4/1/2012–9/30/2012, 10/1/2012 or later).  A 
smoking ban was implemented in all Boston public housing units beginning 
October 1, 2012 and the enrollment time variable is meant to proxy a dose-
response effect where participants recruited temporally closer to the ban might 
be more likely to think about quitting and those recruited after the ban was 
implemented would be most likely to quit.   
Outcome Measures 
 
 Biochemically verified 30-day point prevalence abstinence (PPA) was 
assessed at 3-month and 12-month follow-up where participants self-reported 
smoking abstinence in the past 30 days.  Those who self-reported 7 days of 
abstinence from smoking (not even a puff) were biochemically verified using a 
carbon monoxide (CO) monitor test where exhaled CO of ≤8 parts per million 
(PPM) was considered abstinent19. Those who self-reported abstinence but had 
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high CO as well as those with missing data were re-coded as smokers.   
Mediator Measures 
 
Four potential mediators of the intervention effect on 30-day PPA at 3-
month and 12-month follow-up were examined.  Utilization of the Massachusetts 
Quitline or local clinic-based programs was defined as called or been called by 
the Quitline or gone to a program at a hospital or neighborhood health center that 
had individual counseling or groups to help stop smoking. For 3-month 
outcomes, utilization was considered as use since baseline and for 12-month 
outcomes, utilization was considered at any point over the course of the study 
period. NRT use was defined as self-reported use of any NRT medications, 
including patches, gum, lozenges, inhaler, or nasal spray.  For 3-month 
outcomes, NRT use was considered as use since baseline and for 12-month 
outcomes, NRT use was considered at any point over the course of the study 
period. Motivation to quit was assessed by the “Readiness to Quit Ladder” 56, a 
10-point ordinal measure of motivation with respect to readiness to quit smoking.  
Responses range from “1-I have no interest in quitting” to “10-I have quit 
smoking”.  Motivation to quit was only assessed for smokers who did not report 
abstinence.  Self-efficacy to quit was assessed by the Smoking Situations 
Confidence Inventory57, a 15-item questionnaire which assessed confidence to 
resist smoking in a variety of tempting smoking situations.  Each item response 
was a 10-point Likert scale of confidence to not smoke.  Scores were summed 
across the 15 items and the total measures of self-efficacy to quit (range 15–150) 
 16 
were then binned into 9 categories for analysis.     
Moderator Measures 
 
Variables assessed as potential moderators of the intervention effect on 
30-day PPA were sociodemographic variables including age (dichotomized as 
18–39 and 40+), gender (Female vs. Male), and ethnicity (defined as Hispanic, 
Black non-Hispanic, White/Other non-Hispanic).  Smoking variables included 
nicotine dependence level assessed using the 5-item Fagerstrom Scale, which 
measures number of cigarettes per day and dependent behaviors such as 
smoking soon after waking or when sick in bed54,58.  Individual items are variably 
scored and the total item scale ranges from 1–10.  Scores were dichotomized 
using a cutoff score of 5 where <5 indicates low to moderate dependence and >= 
5 indicates moderate to high dependence.  Presence of other smokers was 
defined as the number of other people living in the household who currently 
smoke.  Categorization was at least one other smoker in the house versus no 
other smokers.   Perceived stress was assessed using the abbreviated version of 
the 10-item Perceived Stress Scale59 which measures how often an individual 
has experienced stressful feelings in the past month, particularly feelings of 
unpredictability, lack of control, and being overwhelmed.  Responses vary from 
“Never” to “Very Often” and the total scale ranges from (0–17) with higher scores 
indicating greater perceived stress.  Total scores were dichotomized to assess 
moderation.  Perceived social support was evaluated using the Interpersonal 
Support Evaluation List (ISEL)60,61 which measures individuals’ perception of the 
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availability of four types of support: appraisal (someone to talk to about one’s 
problems); belonging (people with whom one can do things); tangible (material 
aid); and self-esteem (praise from others or of positive social comparisons).  
Individual items were scored 0 to 3 (0= Definitely false, 3= Definitely true, range 
0–24) with greater scores indicating greater levels of social support.  Total scores 
were dichotomized to assess moderation. 
Model Building 
Directed acyclic graphs (DAGs) of the relationships between the 
intervention, 30-day PPA and potential mediators were created using the 
rationale stated above, as informed by theoretical knowledge and the literature 
(Figure 3).  Covariates were chosen based on potential for confounding of the 
relationships represented in the DAG.  Crude distributions of potential covariates 
by intervention group were examined and variables with unequal distribution 
between intervention and control groups and/or known to be theoretically 
associated with the intervention-cessation relationships were included in the 
propensity score model for confounder control.  Logistic regression was used to 
calculate the crude association between the intervention and 30-day PPA for 
comparison to adjusted estimates.  The model used an exchangeable correlation 
structure to account for potential similarities between participants in the same 
public housing site arising from the group-randomized design.   
Propensity score adjustment methods were chosen to minimize bias from 
potential confounders, while also allowing for adjustment of more potential 
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covariates than the number of cessation events for this analysis would allow62.  
Since propensity scores were more efficient for confounder control than adding 
individual covariate terms to the outcome model, a propensity score model that 
predicted intervention status was constructed using all potential covariates.  
These covariates were race, enrollment time, health, depression, nicotine 
dependence, age, gender, cigarettes per day, lifetime quit attempts, NRT use in 
the past 12 months, motivation to quit, and self-efficacy to quit.  Propensity score 
distributions were compared between intervention and control groups to ensure 
sufficient overlap (Figure 2) and the propensity score values were included as an 
individual covariate in the final mediation and moderation models. 
Mediation Statistical Analyses 
To examine mediators of the association between the intervention and 30-
day PPA, all mediation analyses utilized a macro published by Valeri and 
VanderWeele21.  This method is based on a counterfactual approach to 
mediation where the total effect of the exposure on outcome is decomposed into 
direct and indirect effects.  This separation allows determination of both the 
estimated magnitude and precision of the total, direct, and indirect effects by 
examining their estimates and confidence intervals directly.  The effect of the 
intervention and the effect of the intervention combined with the potential 
mediator was assessed using logistic regression models and bootstrapping 
techniques were used to estimate standard errors and confidence intervals.  The 
model used an exchangeable correlation structure to account for potential 
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similarities between participants in the same public housing site arising from the 
group-randomized design.   
Given the intervention A, smoking cessation, Y, mediator, M, and a 
potential vector of covariates C, consider the following regression models: 
(1) logit{P(Y=1|a,m,c)} = θ0 + θ1a + θ2m +  θ’3c 
(2) logit{P(M=1|a,c)} = β0 + β1a +β’2c 
From these models, odds ratios for the natural direct effect (NDE) and 
natural indirect effect (NIE) will be calculated according to the following.   
(1) ORNDE = 
𝑒𝑥𝑝(θ1𝑎1){1+𝑒𝑥𝑝( 𝜃2 + 𝛽0 + 𝛽1𝑎0 +𝛽’2𝑐)}
ex𝑝(θ1𝑎0){1+𝑒𝑥𝑝( 𝜃2 + 𝛽0 + 𝛽1𝑎0 +𝛽’2𝑐)}
 
(2) ORNIE = 
{1+𝑒𝑥𝑝(𝛽0 + 𝛽1𝑎0 +𝛽’2𝑐)}{1+exp ( 𝜃2 + 𝛽0 + 𝛽1𝑎1 +𝛽’2𝑐)
{1+𝑒𝑥𝑝(𝛽0 + 𝛽1𝑎1 +𝛽’2𝑐)}{1+exp ( 𝜃2 + 𝛽0 + 𝛽1𝑎0 +𝛽’2𝑐
 
The natural direct effect expresses how much the outcome would change 
if the exposure were set at a level A=1 versus A=0 (i.e., intervention vs. control 
arm) and the mediator takes on the value it would have in the absence of 
exposure (i.e., control arm).  The natural indirect effect expresses how much the 
outcome would change if the mediator were changed from the level it would take 
if A=0 versus A=1 if the exposure level itself were controlled at level A=1.  The 
total effect can be defined as how much the outcome would change overall for a 
change in the exposure from level a=0 to a=1; the total effect is equal to the 
product of the natural direct effect and natural indirect effect when odds ratio 
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measures are used63.   
The outcome of 30-day PPA at 3-month follow-up was examined with 
potential mediators of Quitline or local clinic program use and NRT use at 3-
month follow-up.  For the outcome of 30-day PPA at 12-month follow-up, 
mediators of Quitline/local clinic program use and NRT use were assessed at 12-
month follow-up and were defined as ever use of these cessation services across 
the study period.  Motivation to quit and self-efficacy to quit for 12-month 
cessation outcomes were assessed at 7-month follow-up and 3-month follow-up 
if 7-month was missing.  Use of these mediator values at 7-month then 3-month 
instead of 12-month was to prevent issues of reverse causality where 
participants’ smoking status at 12-months may have influenced their responses 
regarding motivation or self-efficacy to quit at 12-months.   Additionally, smokers 
who were quit previously at either the 3-month or 7-month follow-up were 
excluded from the self-efficacy to quit mediation analysis, since the self-efficacy 
scale itself was asked of all participants and not just those who were still smoking 
(as the motivation to quit measure).  Again, the exclusion of previously quit 
smokers was to prevent the potential for reverse causality where smokers who 
may have quit at either the 3-month or 7-month follow-up, but not the 12-month 
follow-up, may have reported increased self-efficacy to quit based on their 
previous smoking cessation status. 
In addition to exposure-outcome confounders, control is also required for 
potential confounders of the mediator-outcome association (Figure 3).  Based on 
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theoretical knowledge of smoking cessation, motivation to quit and self-efficacy 
to quit at baseline were also controlled for as mediator-outcome confounders.  
Both potential confounders of the exposure-outcome and mediator-outcome 
relationships were assessed at baseline and incorporated into a single propensity 
score model.  The propensity score was included as a covariate in the final 
mediation models.   
When a mediating effect is detected, the proportion of the overall effect that is 
explained by the potential mediator will be calculated on the difference scale.  
This measure is applicable when the outcome is dichotomous, odds ratios are 
calculated, and the outcome is sufficiently rare63.  Since all of these requirements 
are satisfied for this effect, the proportion mediated is as follows: 
𝑂𝑅𝑁𝐷𝐸(𝑂𝑅𝑁𝐼𝐸 − 1)
(𝑂𝑅𝑁𝐷𝐸  𝑥 𝑂𝑅𝑁𝐼𝐸 − 1 )
 
 
Moderation Statistical Analyses 
To examine moderators of smoking cessation at both 3-month and 12-month 
follow-up, logistic regression was used to predict smoking cessation outcomes 
among groups for whom intervention effects were hypothesized to differ.  Crude 
stratified analyses were conducted to determine the effect of the intervention on 
30-day PPA among those with and without the potential moderator measured at 
baseline.   
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To measure interaction on an additive scale, the intervention and potential 
moderator were then redefined such that they were considered jointly as a single 
composite exposure, defined by exposure or non-exposure to the intervention 
and the moderator.  A model with the intervention, moderator and the joint 
exposure variable was generated using generalized estimating equations (GEE) 
using an exchangeable correlation structure to account for similarities between 
participants in the same public housing site.  The resulting beta estimates were 
used to calculate the relative excess risk due to interaction (RERI).  Confidence 
intervals around the RERI were calculated using the beta coefficients and 
covariance matrix values from the newly coded indicator variables for the 
exposure categories64.  
To measure interaction on a multiplicative scale, an interaction term was 
created using the same GEE model and the beta term was exponentiated to 
express the ratio of odds ratios (ROR)65.  All final models were adjusted for 
potential confounders at baseline using the propensity score methods outlined 
above.    
Multiple Imputation 
To account for potential bias due to loss to follow-up, multiple imputation 
procedures were used to impute missing mediator and outcome information.  
Using Markov chain Monte Carlo (MCMC) simulation, biochemically-verified past 
30-day PPA, Quitline or local clinic program use, NRT use, motivation to quit, 
and self-efficacy to quit were imputed.  These variables were predicted from a 
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model that included race, enrollment time, health, depression and nicotine 
dependence, which were found to predict missingness.  A total of n=10 imputed 
datasets were created and analyzed using the PROC MI procedure in SAS v9.4.   
RESULTS 
Demographic and Smoking Characteristics 
Of the 331 eligible participants, n=240 participants completed the 3-month 
follow-up questionnaire and n=250 participants completed the 12-month follow-
up questionnaire. 
At baseline (Table 1), participants were mostly female (72%) and greater 
than age 40 (68%).  The distribution of race/ethnicity was 56% Black, 25% 
Hispanic and 19% White/Other.  While 48% had a high school diploma or 
equivalent, 29% had less than a high school education.  Fifty-nine percent 
reported they were in Good, Very Good or Excellent health and 39% screened 
positive for depression according to the CES-D-10.  A majority (57%) of 
participants smoked 10 cigarettes or less cigarettes per day and 63% of the 
participants were classified as having low to moderate dependence on nicotine 
based on the Fagerstrom Test for Nicotine Dependence.  Most (88%) reported at 
least one lifetime quit attempt and 47% reported NRT use in the past 12 months.  
Motivation to quit was high (78%) for the total sample at baseline.  Participant 
characteristics were similar for those who completed a 3-month follow-up and 
among those who completed a 12-month follow-up.   
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3-Month Follow-Up 
Mediation  
Quitline or local clinic program use  
The odds ratio (OR) for the adjusted marginal total effect was 1.88 (0.72 – 
4.93) and the OR for the adjusted natural direct effect was 1.89 (0.72 – 4.97).  
The lack of difference between these estimates suggests Quitline or local clinic 
program use did not mediate the intervention effect on 30-day PPA.  The OR for 
the adjusted natural indirect effect was 1.00 (0.91 – 1.09) and further indicates 
Quitline or local clinic program was not a mediator (Table 2).   
NRT use 
The OR for the adjusted marginal total effect was 1.88 (0.72 – 4.94) and 
the OR for the adjusted natural direct effect was 1.90 (0.72 – 5.02).  Similarity of 
these estimates suggests NRT use did not mediate the intervention effect on 30-
day PPA.  The OR for the adjusted natural indirect effect was 0.99 (0.89 – 1.10) 
and provides additional evidence NRT use was not a mediator (Table 2).   
 Moderation  
Gender 
 Sub-group analyses suggest a greater effect of the intervention among 
females [OR=2.28 (0.93 – 5.62)] versus males [OR=1.25 (0.10 – 15.02)].  The 
measure of interaction on the additive scale was 0.93 (-1.96 – 3.83) and on the 
multiplicative scale was 1.32 (0.11 – 16.60).  Both measures suggest gender was 
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not a moderator of the intervention effect on 30-day PPA.   
Age 
 Sub-group analyses suggest a greater effect of the intervention among 
younger participants [OR=2.78 (0.84 – 9.17)] versus older [OR=1.34 (0.44 – 
4.11)].  The measure of interaction on the additive scale was 0.66 (-2.83 – 4.15) 
and on the multiplicative scale was 1.12 (0.21 – 6.07).  Both measures suggest 
age was not a moderator of the intervention effect on 30-day PPA. 
Race 
 Due to small sample size, Mantel-Haenszel adjusted risk differences for 
the effect of intervention by race were calculated instead of odds ratios.  Sub-
group analyses indicate a greater effect of the intervention among Hispanics 
[0.0561 (-0.1597 – 0.2719)] and Blacks [0.0495 (-0.0569 – 0.1559)] versus 
Whites [0.0298 (-0.1399 – 0.1996)].  Measures of interaction on both the additive 
and multiplicative scale were not calculated due to convergence issues.   
Nicotine dependence 
Sub-group analyses suggest a greater effect of the intervention among 
those with low to moderate nicotine dependence [OR=2.21 (0.75 – 6.53)] versus 
those with moderate to high dependence [OR=0.74 (0.12 – 4.45)].  The measure 
of interaction on the additive scale was 2.23 (-2.77 – 7.23) and on the 
multiplicative scale was 1.42 (0.19 – 10.82).  Both measures suggest low to 
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moderate nicotine dependence could be a moderator of the intervention effect on 
30-day PPA.   
Other smokers in the household 
Sub-group analyses suggest a greater effect of the intervention among 
those with no other smokers in the household [OR=3.40 (0.90 – 12.82)] versus 
those with other smokers in the household [OR=1.02 (0.32 – 3.25)].  The 
measure of interaction on the additive scale was 2.22 (-0.51 – 4.95) and on the 
multiplicative scale was 4.16 (0.79 – 21.74).  Both measures suggest other 
smokers in the household had a moderating role in the association between the 
intervention and 30-day PPA where the TTA intervention was more impactful for 
those who did not live with another smoker.   
Perceived stress 
Sub-group analyses suggest a similar effect of the intervention among 
those with higher perceived stress [OR=1.79 (0.33 – 9.76)] and those with lower 
perceived stress [OR=1.97 (0.77 – 5.07)].  The measure of interaction on the 
additive scale was -0.68 (-4.12 – 2.77) and on the multiplicative scale was 0.65 
(0.09 – 4.67).  Both measures suggest perceived stress was not a moderator of 
the intervention effect on 30-day PPA.   
Social support 
Sub-group analyses suggest a greater effect of the intervention among those 
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with higher social support [OR=2.17 (0.99 – 4.74)] versus those with lower social 
support [OR=0.85 (0.16 – 4.42)].  The measure of interaction on the additive 
scale was 0.19 (-2.05 – 2.42) and on the multiplicative scale was 1.54 (0.18 – 
13.16).  Both measures suggest social support was not a moderator of the 
intervention effect on 30-day PPA.   
 Table 3 shows effect of the intervention on 3-month cessation stratified by 
the potential moderators.  Table 4 presents 3-month moderation measures on 
the additive and multiplicative scales. 
Multiple Imputation 
 
 Using multiple imputation procedures to account for potential bias from 
loss to follow-up, the mediation analyses and moderation analyses were 
repeated with the full n=331 participants at baseline.  Results were similar to the 
complete-case analyses and overall conclusions on potential mediators and 
moderators at 3-month follow-up were unchanged (Table 5).   
Summary  
At 3-month follow-up, neither Quitline/local clinic program use nor NRT 
use were mediators of the effect of the intervention on 30-day abstinence.  The 
intervention seemed to have a greater effect on cessation among those who did 
not live with a smoker versus those who did.  However, the width of the 
confidence intervals for measures of interaction limits the reliability of these 
moderation conclusions. 
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12-Month Follow-Up 
Mediation  
Quitline or local clinic program use  
The OR for the adjusted marginal total effect was 2.28 (0.91 – 5.71) and 
the OR for the adjusted natural direct effect was 2.53 (1.01 – 6.33).  The OR for 
the adjusted natural indirect effect was 0.90 (0.80 – 1.02).  While the point 
estimate of the natural direct effect is greater in magnitude than the marginal total 
effect, the confidence interval of these estimates in addition to the natural indirect 
estimate itself suggest no mediated effect (Table 6).   
NRT use 
The OR for the adjusted marginal total effect was 2.30 (0.91 – 5.81) and 
the OR for the adjusted natural direct effect was 2.36 (0.94 – 5.95).  Similarity of 
these estimates suggests NRT use did not mediate the intervention effect on 30-
day PPA.  The OR for the adjusted natural indirect effect was 0.98 (0.90 – 1.06) 
and provides additional evidence NRT use was not a mediator (Table 6).   
Motivation to quit 
The OR for the adjusted marginal total effect was 2.28 (0.58 – 8.96) and 
the OR for the adjusted natural direct effect was 2.70 (0.93 – 7.83).  The OR for 
the adjusted natural indirect effect was 0.85 (0.36 – 1.98).  Similarity of the 
marginal total and natural direct estimates suggests motivation to quit did not 
mediate the intervention effect on 30-day PPA.  In addition, the width of the 
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confidence interval for the natural indirect effect supports the lack of mediation by 
motivation (Table 6).   
Self-efficacy to quit 
The OR for the adjusted marginal total effect was 3.00 (0.57 – 15.76) and 
the OR for the adjusted natural direct effect was 2.22 (0.47 – 10.58).  The OR for 
the adjusted natural indirect effect was 1.35 (0.57 – 15.76).   The indirect effect 
and the greater magnitude of the marginal total effect versus the natural direct 
effect suggests there could be a mediating effect of the intervention via self-
efficacy.  The proportion of the total effect mediated by self-efficacy to quit was 
38.9% (Table 6). 
Moderation  
Gender 
 Sub-group analyses suggest a greater effect of the intervention among 
females [OR=3.03 (1.63 – 5.62)] versus males [OR=1.62 (0.11 – 24.14)].  The 
measure of interaction on the additive scale was 2.10 (-1.59 – 5.78) and on the 
multiplicative scale was 1.56 (0.26 – 9.48).  Both measures suggest gender was 
not a moderator of the intervention effect on 30-day PPA.   
Age 
 Sub-group analyses suggest a greater effect of the intervention among 
younger participants [OR=4.87 (1.02 – 23.11)] versus older [OR=2.04 (0.97 – 
 30 
4.27)].  The measure of interaction on the additive scale was 0.92 (-1.40 – 3.25) 
and on the multiplicative scale was 2.03 (0.20 – 20.78).  Both measures suggest 
age was not a moderator of the intervention effect on 30-day PPA. 
Race 
 Due to small sample size, Mantel-Haenszel adjusted risk differences for 
the effect of intervention by race were calculated instead of odds ratios.  Sub-
group analyses suggest a greater effect of the intervention among Whites 
[0.0922 (-0.0404 – 0.2249)] and Hispanics [0.0171 (-0.2069 – 0.2412)] versus 
Blacks [-0.0739 (-0.0288 – 0.1766)].  Measures of interaction on both the additive 
and multiplicative scale were not able to be calculated due to convergence 
issues.   
Nicotine dependence 
Sub-group analyses suggest a greater effect of the intervention among 
those with moderate to high nicotine dependence [OR=4.16 (0.44 – 39.34)] 
versus those with low to moderate dependence [OR=1.55 (1.04 – 2.33)].  The 
measure of interaction on the additive scale was -1.98 (-13.49 – 9.54) and on the 
multiplicative scale was 0.24 (0.02 – 2.37).  Both measures suggest low to 
moderate nicotine dependence was not a moderator of the intervention effect on 
30-day PPA due to the width of the confidence intervals.   
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Other smokers in the household 
Sub-group analyses suggest a similar effect of the intervention among 
those with no other smokers in the household [OR=3.31 (1.29 – 8.47)] versus 
those with other smokers in the household [OR=2.36 (1.21 – 4.58)].  The 
measure of interaction on the additive scale was 0.57 (-2.03 – 3.17) and on the 
multiplicative scale was 1.42 (0.40 – 5.04).  Both measures suggest other 
smokers in the household was not a moderator of the intervention effect on 30-
day PPA.   
Perceived stress 
Sub-group analyses suggest a greater effect of the intervention among 
those with lower perceived stress [OR=5.55 (2.06 – 14.97)] versus those with 
higher perceived stress [OR=0.76 (0.31 – 1.85)].  The measure of interaction on 
the additive scale was 1.61 (-0.14 – 3.35) and on the multiplicative scale was 
4.84 (0.85 – 27.64).  Both measures suggest perceived stress may have played 
a moderating role in the effect of the intervention on 30-day PPA such that the 
effect of the intervention was greater among those with low perceived stress. 
Social support 
Due to small sample size, Mantel-Haenszel adjusted risk differences for 
the effect of intervention by social support were calculated instead of odds ratios.  
Sub-group analyses suggest a similar effect of the intervention among those with 
high perceived social support [0.0912 (-0.0034 – 0.1857)] and among those with 
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low perceived social support [0.0905 (-0.0966 – 0.2776)].  Measures of 
interaction on both the additive and multiplicative scale were not able to be 
calculated due to convergence issues.   
Table 7 shows effect of the intervention on 12-month cessation stratified 
by the potential moderators.  Table 8 presents 12-month moderation measures 
on the additive and multiplicative scales.   
Multiple Imputation 
 
 Using multiple imputation procedures to account for potential bias from 
loss to follow-up, the mediation analyses and moderation analyses were 
repeated with the full n=331 participants at baseline.  Results were similar to the 
complete-case analyses and overall conclusions on potential mediators and 
moderators at 12-month follow-up were unchanged (Table 9).   
Summary  
At 12-month follow-up, self-efficacy to quit was a mediator of the effect of 
the intervention on 30-day abstinence.  The intervention had a greater effect on 
cessation among those with low perceived stress versus those with high 
perceived stress.  Again, the width of the confidence intervals for measures of 
interaction limit the reliability of moderation conclusions. 
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DISCUSSION 
Findings on Mediation 
 There was a lack of evidence for mediation by Quitline or local clinic 
program use at both 3-month and 12-month follow-up.  Similarly, NRT use was 
also not a mediator of the relationship between the intervention and 30-day PPA 
outcomes.  Use of telephone quitlines and local clinic programs has been shown 
to help smokers quit5.  Additionally, NRT such as patches, gum, and lozenges 
are first-line pharmacotherapy medications recommended by clinicians to help 
smokers quit.  However, neither of these evidence-based methods of quit 
smoking were significant mediators in our study.  Furthermore, the direct effect of 
the intervention was highly similar to the total marginal effect in all mediation 
analyses for utilization and NRT use, suggesting while overall utilization of the 
Quitline or local clinic programs and NRT use increased, the TTA intervention 
itself had the most direct impact on getting smokers to quit.   
Recent studies have shown that engagement with a telephone quitline is 
associated with smoking cessation in low-income populations66,67.  However, 
there remains the barrier to accessing quitlines or local clinic programs, which 
was evident in our study population as only 22% reported use of the Quitline or 
local clinic program over the entire study period.  While overall utilization was 
lower, it could also be that engagement with telephone quitlines in isolation did 
not necessarily lead to smoking cessation in this population.   
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Similarly, NRT use is known to be effective in increasing the probability of 
smoking cessation, although did not have a significant mediating effect in this 
study.   Again, it could be that NRT use does not necessarily translate to 
cessation among low-income populations.  One smoking cessation intervention 
trial68 among smokers of low socioeconomic status found no difference in quitting 
by NRT use.  Absolute rates of NRT use throughout our study, while higher than 
utilization rates, were also relatively low (40%) and may have contributed to the 
tenuous relationship with smoking cessation.  The cumulative nature of the NRT 
use measurement may also not have been temporally relevant for smoking 
cessation.  For example, an individual who reported NRT use at 3-month follow-
up, but not 7-month or 12-month follow-up would still be considered an ever user 
of NRT for the 12-month mediation analysis.  This mediator measurement may 
have been too distant from the outcome measurement to have a meaningful 
effect.  The lack of mediating effects found for utilization or NRT use suggests 
the intervention likely operated through other pathways we did not explore to 
increase smoking cessation rates.   
There were differentiating components of the TTA intervention that may 
have contributed to its overall positive effect on smoking cessation in this 
socioeconomically disadvantaged population.  First, TTAs were residents of 
public housing themselves and met with participants in their homes with the 
potential for multiple follow-up visits.  This likely helped the interventionist 
establish rapport with the participants and contributed to participant buy-in of the 
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intervention materials.  Second, participants reported high satisfaction with their 
TTAs.  It could be that they liked the support from the TTA so much that they did 
not feel the need to obtain additional support from the cessation resources 
provided.  Finally, the intervention emphasized social support which is shown to 
help racially/ethnically diverse smokers quit15.  Not only did the TTAs provide 
social support in the context of the intervention, it is possible that smokers may 
have found further social support from their public housing peers who may have 
also been enrolled in the study.   
At 12-month follow-up, motivation to quit was not a mediator of the 
intervention effect on 30-day PPA.  This result is surprising given that the 
intervention utilized motivational interview techniques with the intent of increasing 
motivation to quit.  At baseline, 78% of the study sample reported high levels of 
motivation to quit, so there may have been a ceiling effect of the intervention on 
increasing this measure.  Our results echo a study of treatment-seeking 
smokers69 which also found motivation to quit does not predict abstinence, and 
where mean baseline motivation to quit was 12.0 on a scale ranging from 6–14.  
It could also be that motivation to quit did not have an impact on cessation 
outcomes specifically, but could have impacted more intermediate measures.   
For example, studies have shown motivation to quit predicts number of quit 
attempts, but not smoking abstinence70,71.  It could also be that motivation to quit 
is a dynamic psychological state and measuring the variable at earlier time 
points, to avoid the potential for reverse causality, resulted in no impact on 
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cessation outcomes seen at 12-months.  Ideally, motivation to quit would be 
evaluated using ecological momentary assessments (EMA) to achieve more 
frequent and real-time measures of motivation to quit prior to evaluating 
cessation outcomes.  This should be a consideration when evaluating dynamic 
psychological variables in future mediation studies.   
Increased self-efficacy was a potential mediator of the intervention effect 
on 30-day PPA at 12-month follow-up with an indirect effect of 1.35 (0.57 – 
15.76).  These results suggest the TTA intervention boosted intervention 
participants’ confidence to not smoke in a variety of tempting situations and this 
increased confidence helped smokers stay abstinent from cigarettes for at least 
30 days.  It is known that increased self-efficacy is associated with smoking 
abstinence as being able to resist temptations to smoke is an integral component 
to achieving and maintaining abstinence37,72,73.  Increasing self-efficacy was also 
a major target of the KIG intervention as “Building Confidence to Quit” was an 
intervention visit topic.   
Our mediation findings are similar to other intervention studies that found 
self-efficacy to mediate the effect on cessation.  Graham, et al.74 showed quitting 
confidence was a significant mediator of an internet and telephone treatment 
intervention on 30-day PPA at 3-month follow-up.  A longitudinal study75 that 
offered telephone-based counseling and NRT showed self-efficacy mediated 7-
day PPA at 12-month follow-up.  Among persons living with HIV/AIDS76, self-
efficacy was found to mediate the effect of a cell-phone intervention on 7-day 
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PPA at 3-month follow-up, and accounted for 17% of the total intervention effect.  
In our study, self-efficacy accounted for 39% of the intervention effect on 
sustained abstinence of 30 days at 12-month follow-up.  These results are highly 
encouraging and offer insight on pathways to cessation for low-income and 
racially/ethnically diverse smokers.  Increasing self-efficacy to quit should be 
highlighted in future interventions for these vulnerable populations. 
Findings on Moderation 
Number of other smokers in the household was a moderator of the 
intervention effect on 30-day PPA outcomes at 3-month follow-up.  Among those 
who did not live with other smokers, intervention participants were more than 
three times as likely to report abstinence versus control participants.  However, 
among those who lived with at least one or more smokers, intervention 
participants were just as likely to report abstinence as control participants.  
Studies show in a variety of populations that living with other smokers has a 
negative impact on smoking cessation and relapse outcomes77–80. Interestingly, 
number of other smokers in the household did not moderate the effect of the 
intervention on 30-day PPA at 12-month follow-up.  Among those who did not live 
with other smokers, intervention participants were still more than three times as 
likely to report abstinence versus control participants.  In contrast to the 3-month 
results, among participants who lived with at least one or more smokers, 
intervention participants were more than twice as likely to report abstinence as 
control participants.  While living with other smokers may hinder cessation efforts 
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by increasing temptation and access to tobacco, living with other smokers did not 
completely prevent cessation in this study as intervention participants were 
eventually able to quit at 12-month follow-up.  Thus, the effects of the 
intervention were evident but delayed for those living with other smokers.  These 
results should be considered when designing future interventions as a smoker’s 
home environment, where possible, should maximize potential to quit smoking.  
However, our study shows achieving abstinence is possible even for those who 
do live with other smokers.   
At 12-month follow-up, perceived stress was a moderator of the 
intervention effect on 30-day PPA.  Among those with low perceived stress, 
intervention group participants were more than five times as likely as the control 
group to report smoking abstinence.  Among those with high perceived stress, 
intervention group participants were not any more likely to report abstinence as 
the control group.  These results support previous studies that show stress is 
associated with poor smoking related outcomes, particularly for low-income 
individuals who may smoke to manage stress81–84.  Interestingly, stress was not a 
moderator of the intervention on 30-day PPA at 3-month follow-up.  During this 
time, the intervention period was ongoing and participants in the intervention 
group could still engage with their TTA.  The negative effects of stress may have 
been buffered by the contact with and social support from the TTA whereas at 
12-month follow-up the intervention period was too temporally distant to have an 
effect.    
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We did not find evidence of moderation of the intervention effect on 30-
day PPA at any follow-up for age, gender, or race.  Point estimates suggest both 
male and female intervention participants were more likely to quit than control 
participants.  Similarly, both younger and older intervention participants were 
more likely to quit than control participants.  These results suggest that being 
male and older does not hinder successful cessation, even though studies have 
shown that both male smokers and older smokers are less likely to quit smoking 
than their female and younger counterparts45,85,86.  Note, these moderation 
results for gender and age should be cautiously interpreted due to the large width 
of the confidence intervals.  As another matter of power, due to the lack of control 
participants who did not report smoking abstinence among Whites, we could not 
assess moderation by race.  However, comparing raw proportions suggests that 
intervention participants had a higher probability of cessation for Whites (9.4% 
vs. 0.0%), Blacks (13.5% vs. 4.6%), and Hispanics (21.7% vs. 15.2%) at 3-month 
follow-up.  Results were similar for Whites and Blacks at 12-month follow-up 
although quit rates among Hispanics were comparable for the intervention 
(17.9%) and control (19.2%) groups.  These results contrast the extensive body 
of literature that has shown in a variety of populations that Blacks and Hispanics 
are more likely to have higher smoking rates and less likely to quit smoking than 
Whites6,43,87–89. However, in a study by Asvat, et al.90 which was similar to the 
KIG study and examined the effectiveness of a community-based smoking 
cessation intervention in a racially diverse, urban smoker cohort, there were no 
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differences in quit rates between African Americans and Whites.  Again, cautious 
interpretations of our results are warranted due to the lack of power to assess 
moderation by race, but it is encouraging that the TTA intervention was able to 
promote cessation among racial and ethnic minorities.   
There was no evidence of moderation by nicotine dependence although 
the point estimates of the effect of the intervention was positive for those with low 
to moderate nicotine dependence and negative for those with moderate to high 
nicotine dependence at 3-month follow-up.  At 12-month follow-up, the effect was 
positive for both groups and actually greater for those with moderate to high 
nicotine dependence.  While the literature illustrates greater nicotine dependence 
hinders smoking cessation efforts through reduced quit attempts and lower 
probability of abstinence91–93, the 12-month data show contrasting results.  
Similar to living with other smokers, it could be that those with greater 
dependency on nicotine may take longer for the intervention to have an effect on 
their quit status, but they are eventually able to achieve abstinence.  Again, the 
large random error component leads to tenuous conclusions about these results.  
The moderating effect of nicotine dependence on smoking cessation intervention 
effects on smoking abstinence should be further explored in socioeconomically 
disadvantaged populations. 
There was also no evidence of moderation by social support of the 
intervention effect on 30-day PPA at both follow-up time points.  While it is 
established that greater social support is associated with smoking cessation, it 
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could be that these results are not translatable to those living in public 
housing61,94,95.  For example, a majority (75%) of our study population reported 
high social support levels.  Even among those with low social support at 12-
month follow-up, a greater proportion of the intervention group (16.7%) were able 
to quit smoking versus the control group (11.1%). 
There are important insights from our findings that may be applied to the 
design and conduct of smoking cessation interventions among socioeconomically 
disadvantaged populations.  First, the direct effect of the TTA intervention was 
consistently greater than any mediated pathway.  Future studies should consider 
using the unique elements of the TTA intervention, including public housing 
residents trained as community health workers and a motivational interviewing-
based intervention, instead of focusing resources on increasing utilization of 
cessation services such as a telephone quitline.  There was also evidence for the 
mediated effect on cessation via self-efficacy to quit; thus, future studies could 
also focus on increasing participants’ confidence to quit smoking and maintain 
abstinence.  Controlling the smoking environment can be futile or immutable, but 
where possible interventions should teach smokers how to minimize their contact 
with other smokers to reduce potential triggers and cravings for cigarettes.  
Finally, to maintain long-term abstinence stress may play a moderating role and 
so smokers should also be trained to deal with life stressors appropriately so as 
to encourage a psychosocial environment conducive to quitting. 
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Strengths and Limitations 
 
Overall, there were limitations of using data from the Kick it for Good Study to 
assess mediation and moderation.  Randomization of the KIG study was at the 
level of the group and not the individual.  Due to the small number of public 
housing sites randomized (n=26), we did not have a balance of individual-level 
characteristics between the intervention and control groups.  Thus, potential 
confounding had to be sufficiently controlled through the use of propensity 
scores.  Due to the relatively small number of participants enrolled in the study 
(n=331) and follow-up rates that ranged from 73–76%, there was considerable 
imprecision in model estimates and reduced power to detect significant 
differences.  Previous analyses using KIG data have shown that appropriate 
control for potential confounders yields meaningful effects with sufficient 
precision.  However, the small size of the study particularly hindered the 
moderation analyses where due to the lack of events in certain race and social 
support groups, we could not assess moderation by these factors.  While multiple 
imputation methods were used to increase the amount of data available and our 
results were robust to the complete case analysis, these methods did not remedy 
situations where there were no outcome events.  Finally, the Kick it for Good 
Study was not designed to assess mediation, so the timing of variables was not 
ideal to prevent reverse causality nor to ensure temporal proximity.   
Regarding the mediation analysis specifically, it was difficult to establish 
temporality for the motivation to quit and self-efficacy to quit variables since these 
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variables were assessed at the same time as smoking cessation and may be 
impacted by quit status.  Due to the potential for reverse causality, we could not 
assess the mediating effect of motivation to quit and self-efficacy at 3-month 
follow-up.  To circumvent the issue at 12-month follow-up, motivation to quit and 
self-efficacy to quit were assessed as mediators at 7-months for those who 
completed the 7-month follow-up, then 3-months for those who did not complete 
a 7-month follow-up.  Participants who only completed a baseline and 12-month 
follow-up were then excluded from the mediation analyses (n=23).  While 
motivation to quit and self-efficacy to quit were measured at follow-up time points 
prior to the measurement of cessation, it could still be that these measurements 
were too temporally distant and did not have an impact on cessation.  This may 
explain why there were null results for the mediating effect of motivation to quit, 
although the moderate mediating effect found for self-efficacy to quit supports the 
use of 7-month and 3-month data as temporally relevant mediators.   
Given the multiple follow-up points, it would have been ideal to assess 
mediators as time-varying variables.  This would have been particularly useful for 
the dynamic psychosocial variables (i.e. motivation to quit and self-efficacy to 
quit) and would also have allowed for the use of data at follow-up time points 
despite differing patterns of missingness.  However, assessing time-varying 
mediation using a counterfactual approach was not feasible for two main 
reasons.  First, there was potential for exposure-induced confounding of the 
mediator-outcome relationship, which would have violated a key assumption of 
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the counterfactual approach.  For example, motivation to quit was a key target of 
the intervention and a potential mediator of the intervention effect on cessation.  
It is plausible to believe that motivation to quit would have also impacted self-
efficacy to quit.  This would have resulted in confounding of the mediator-
outcome relationship, which could not be remedied without removing portions of 
the indirect effect of the intervention through the exposure-induced confounder 
(Figure 4).  Second, marginal structural models or inverse probability of treatment 
weighting may be used in analyses examining the effect of an exposure on an 
outcome with time-varying confounders; however, accessible computational 
analysis for counterfactual mediation analysis was not developed at the time this 
dissertation study was initiated.  Since then, in March 2017, Lin, et al.96 published 
a paper using a parametric mediational g-Formula approach to examine time-
varying variables within the framework of a counterfactual mediation analysis. 
The probability of other sources of bias was minimal in this study.  
Confounding was found to be sufficiently controlled through the use of propensity 
scores.  While there were a number of variables that were unbalanced between 
the intervention and control groups, the rarity of cessation events limited the 
number of covariates we could control with sufficient precision.  Controlling for 
confounding using propensity scores allowed us to control for more variables 
than would have been warranted by the number of outcomes.  The final 
propensity score models illustrated sufficient overlap of the propensity score 
distributions between the intervention and control groups.  Not only did using 
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propensity scores indicate more precise estimates of effect than using individual 
covariates in the regression models, it allowed for greater control of confounding 
by including more potential covariates.  Finally, although using propensity scores 
as a regression term is the least preferred method of controlling for propensity 
scores, matching was not viable due to the limited power of this study.  We did 
find stratification methods yielded similar point estimates and confidence 
intervals as regression-based methods.     
 Selection bias was also minimal in this study.  In this low-income 
population, it is unlikely that loss to follow-up would have been impacted by 
cessation outcomes as much as the increasing monetary incentives offered for 
each follow-up assessment.  Among intervention studies that encourage the use 
of pharmacotherapy, there is the potential for users to experience side effects 
from these medications and drop out of the study.  This could have been the 
case since NRT use such as patches have been shown to cause dizziness, 
nausea and vivid dreaming.  However, we found no evidence of a negative 
impact of pharmacotherapy use on follow-up rates.  Furthermore, the use of 
multiple imputation procedures to account for potential loss to follow-up showed 
results that were robust to the complete-case analysis.  
Future Research Directions 
We recommend all mediation findings from this study be replicated in 
other low-income and racially/ethnically diverse samples.  We found a mediating 
effect of self-efficacy, so confirming these results would inform targets for future 
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intervention studies.  We also found a lack of mediation by Quitline or local clinic 
program use, NRT use, and motivation to quit.  If these variables have a true null 
effect on cessation, then future interventions should direct resources elsewhere.  
While the literature suggests they improve cessation rates, it could be that these 
quit methods are not relevant to low-income or racially/ethnically diverse 
smokers.   
There was insufficient power to examine moderators of the intervention, 
particularly for race and social support.  While there was modest evidence for the 
moderating effect of living with other smokers and perceived stress, these should 
be further investigated in a low-income, and racially/ethnically diverse sample.  
The lack of moderation by age and gender should also be studied, especially as 
our participants were generally older than the average population.  In order to 
appropriately assess moderation, future research studies should consider such 
analyses when conducting sample size calculations.  They should also attempt to 
achieve high follow-up rates to ensure sufficient power to detect potential 
moderators in the analysis phase.   
A major limitation of our study was a lack of temporal clarity with respect 
to self-efficacy to quit and smoking cessation.  Future studies should consider 
ecological momentary assessment to not only measure psychosocial mediators 
in advance of the outcome, but also to achieve more granular assessments of 
the smoker’s psychological state prior to cessation. 
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Finally, in this longitudinal study it would have been ideal to assess the 
time-varying effect of the mediators on cessation.  However, due to the lack of 
available software to appropriately adjust for the potential biases associated with 
such an analyses, we were unable to examine mediating effects over time.  
When accessible advancements in programming are made to allow for 
assessment of time-varying counterfactual mediation analyses these should be 
utilized to examine mediators of the effect of smoking cessation interventions on 
abstinence over time. 
Conclusion 
 Using a counterfactual mediation approach, self-efficacy was a mediator 
of the KIG intervention, but not Quitline or local clinic program use, NRT use, or 
motivation to quit.  Living with other smokers and perceived stress were 
moderators of the KIG intervention.  Due to the increased barriers to quitting and 
negative health effects of sustained smoking for low-income and 
racially/ethnically diverse smokers, it is important to understand the mechanisms 
by which smoking cessation interventions operate in these vulnerable 
populations.  Our study adds to the current literature that suggests increasing 
self-efficacy to quit, minimizing contact with other smokers, and managing stress 
may socioeconomically disadvantaged smokers achieve abstinence.  
 48 
Table 1. Baseline demographic, health and smoking characteristics of KIG 
sample 
 Total Sample 
(n=331) 
n (%) 
Intervention 
(n=161) 
n (%) 
Control  
(n=170) 
n (%) 
Age 
   18–39 
   40+ 
 
106 (32.0) 
225 (68.0) 
 
65 (40.4) 
96 (59.6) 
 
41 (24.1) 
129 (75.9) 
Sex 
   Female 
   Male 
 
239 (72.2) 
92 (27.8) 
 
46 (28.6) 
115 (71.4) 
 
46 (27.1) 
124 (72.9) 
Race 
   Hispanic 
   Black 
   White/Other 
 
84 (25.4) 
183 (55.3) 
64 (19.3) 
 
42 (26.1) 
75 (46.6) 
44 (27.3) 
 
42 (24.7) 
108 (63.5) 
20 (11.8) 
Education 
   Less than high school 
   High school or equivalent 
   Some college 
   College graduate 
 
97 (29.3) 
158 (47.8) 
56 (16.9) 
20 (6.0) 
 
45 (28.0) 
74 (46.0) 
31 (19.3) 
11 (6.8) 
 
52 (30.6) 
84 (49.4) 
25 (14.7) 
9 (5.3) 
Health 
   Fair/Poor 
   Good/Very Good/Excellent 
 
136 (41.1) 
195 (58.9) 
 
58 (36.0) 
103 (64.0) 
 
78 (45.9) 
92 (54.1) 
CES-D-10 Depression 
   Yes 
   No 
 
130 (39.3) 
201 (60.7) 
 
75 (46.6) 
86 (53.4) 
 
55 (32.4) 
115 (67.7) 
Cigarettes per day 
   ≤10 
   11+ 
 
189 (57.1) 
142 (42.9) 
 
87 (54.0) 
74 (46.0) 
 
102 (60.0) 
68 (40.0) 
Fagerstrom Test for Nicotine 
Dependence* 
   ≤4 (low to moderate) 
   5+ (moderate to high) 
 
 
207 (62.7) 
123 (37.3) 
 
 
102 (63.8) 
58 (36.3) 
 
 
105 (61.8) 
65 (38.2) 
Lifetime quit attempts 
   0 
   1–3 
   4+ 
 
40 (12.1) 
173 (52.3) 
118 (35.7) 
 
26 (16.2) 
78 (48.5) 
57 (35.4) 
 
14 (8.2) 
95 (55.9) 
61 (35.9) 
Lived with one or more 
smokers in the household* 
   Yes 
   No 
 
 
178 (53.9) 
152 (46.1) 
 
 
90 (56.3) 
70 (43.8) 
 
 
88 (51.8) 
82 (48.2) 
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 Total Sample 
(n=331) 
n (%) 
Intervention 
(n=161) 
n (%) 
Control  
(n=170) 
n (%) 
Quitline or local clinic 
program use past 12 months 
   Yes 
   No 
 
 
29 (8.8) 
302 (91.2) 
 
 
14 (8.7) 
147 (91.3) 
 
 
15 (8.8) 
155 (91.2) 
NRT use past 12 months 
   Yes 
   No 
 
155 (46.8) 
176 (53.2) 
 
72 (44.7) 
89 (55.3) 
 
83 (48.8) 
87 (51.2) 
Motivation to quit  
   Low (1–3) 
   Medium (4–6) 
   High (7–10) 
 
9 (2.7) 
63 (19.0) 
259 (78.3) 
 
2 (1.2) 
31 (19.3) 
128 (79.5) 
 
7 (4.1) 
32 (18.8) 
131 (77.1) 
Self-efficacy to quit 
   Low (15–50) 
   Medium (51–100) 
   High (101–150) 
 
64 (19.3) 
211 (63.8) 
56 (16.9) 
 
40 (24.8) 
104 (64.6) 
17 (10.6) 
 
24 (14.1) 
107 (62.9) 
39 (22.9) 
Social support 
   Low (0–12) 
   High (13–24) 
 
50 (15.1) 
281 (84.9) 
 
28 (17.4) 
133 (82.6) 
 
22 (12.9) 
148 (87.1) 
Stress 
   Low (1–8) 
   High (9–17) 
 
205 (61.9) 
126 (38.1) 
 
97 (60.3) 
64 (39.8) 
 
108 (63.5) 
62 (36.5) 
Enrollment time 
   10/1/2012 or later 
   4/1/2012–9/30/2012 
   3/31/2012 or earlier 
 
143 (43.2) 
122 (36.9) 
66 (19.9) 
 
64 (39.8) 
69 (42.9) 
28 (17.4) 
 
79 (46.5) 
53 (31.2) 
38 (22.4) 
*Missing n=1 
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Table 2. Crude, adjusted and imputed estimates for the direct, indirect and total 
effects of the intervention on 30-day PPA at 3-months accounting for potential 
mediators 
  OR (95% CI) 
Mediator  Natural Direct 
Effect 
Natural Indirect 
Effect 
Marginal Total 
Effect 
Quitline or 
local clinic 
program use 
(n=240) 
Crude 2.24 (0.93 – 5.40) 1.00 (0.88 – 1.14) 2.25 (0.94 – 5.36) 
Adjusted* 1.89 (0.72 – 4.97) 1.00 (0.91 – 1.09) 1.88 (0.72 – 4.93) 
Multiple 
Imputation 
1.81 (0.69 – 4.73) 0.99 (0.86 – 1.14) 1.80 (0.70 – 4.63) 
NRT use 
(n=240) 
Crude 2.27 (0.95 – 5.45) 0.99 (0.89 – 1.09) 2.25 (0.94 – 5.36) 
Adjusted* 1.90 (0.72 – 5.02) 0.99 (0.89 – 1.10) 1.88 (0.72 – 4.94) 
Multiple 
Imputation 
1.76 (0.70 – 4.42) 1.02 (0.88 – 1.17) 1.79 (0.70 – 4.61) 
*Adjusted for baseline confounders race, age, gender, enrollment time, health, 
depression, cpd, nicotine dependence, lifetime quit attempts, previous NRT use, 
motivation to quit and self-efficacy to quit using propensity score methods  
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Table 3. Adjusted 3-month stratified analyses by potential moderators 
3-month 30-day PPA Adjusted OR* (95% CI) Multiple Imputation 
OR (95% CI) 
Gender   
   Female 2.28 (0.93 – 5.62) 2.49 (0.82 – 7.54) 
   Male 1.25 (0.10 – 15.02) 1.55 (0.18 – 13.54) 
Age   
   18–39 2.78 (0.84 – 9.17) 2.66 (0.74 – 9.57) 
   40+ 1.34 (0.44 – 4.11) 1.70 (0.50 – 5.71) 
Race MH-adjusted (pscore) 
Risk Difference 
 
   White/Other 0.0298 (-0.1399 – 0.1996) N/A 
   Hispanic 0.0561 (-0.1597 – 0.2719) N/A 
   Black 0.0495 (-0.0569 – 0.1559) N/A 
Nicotine Dependence   
   Low to Moderate 
Dependence 
2.21 (0.75 – 6.53) 2.29 (0.74 – 7.13) 
   Moderate to High 
Dependence 
0.74 (0.12 – 4.45) 1.43 (0.14 – 14.49) 
Other Smokers in Household   
   Yes 1.02 (0.32 – 3.25) 1.41 (0.32 – 6.20) 
   No 3.40 (0.90 – 12.82) 3.03 (0.95 – 9.67) 
Perceived Stress   
   High 1.79 (0.33 – 9.76) 2.57 (0.57 – 11.65) 
   Low 1.97 (0.77 – 5.07) 1.86 (0.66 – 5.26) 
Social Support   
   High 2.17 (0.99 – 4.74) 2.29 (0.86 – 6.10) 
   Low 0.85 (0.16 – 4.42) 1.85 (0.28 – 12.06) 
*Adjusted for baseline confounders race, age, gender, enrollment time, health, 
depression, cpd, nicotine dependence, lifetime quit attempts, previous NRT use, 
motivation to quit and self-efficacy to quit using propensity score methods 
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Table 4. Three-month moderation measures on the additive (RERI) and 
multiplicative (ROR) scales for potential moderators 
Potential Moderator Additive Scale RERI 
(95% CI) 
Multiplicative Scale 
ROR (95% CI) 
Gender (female) 0.93 (-1.96 – 3.83) 1.32 (0.11 – 16.60) 
Age (18–39) 0.66 (-2.83 – 4.15) 1.12 (0.21 – 6.07) 
Nicotine dependence (<5) 2.23 (-2.77 – 7.23) 1.42 (0.19 – 10.82) 
Perceived stress (low) -0.68 (-4.12 – 2.77) 0.65 (0.09 – 4.67) 
Other smokers in household 
(none) 
2.22 (-0.51 – 4.95) 4.16 (0.79 – 21.74) 
Perceived social support (high) 0.19 (-2.05 – 2.42) 1.54 (0.18 – 13.16) 
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Table 5. Three-month moderation measures on the additive (RERI) and 
multiplicative (ROR) scales for potential moderators using multiple imputation 
procedures 
Potential Moderator Additive Scale RERI 
(95% CI) 
Multiplicative Scale 
ROR (95% CI) 
Gender (female) 1.18 (-1.28 – 3.64) 1.63 (0.13 – 20.96) 
Age (18–39) 0.33 (-1.81 – 2.47) 1.11 (0.19 – 6.39) 
Nicotine dependence (<5) 2.74 (-3.18 – 8.66) 1.14 (0.12 – 11.24) 
Perceived stress (low) -0.83 (-5.50 – 3.84) 0.63 (0.10 – 4.15) 
Other smokers in household 
(none) 
1.43 (-1.24 – 4.11) 2.30 (0.39 – 13.57) 
Perceived social support (high) -0.10 (-3.23 – 3.03) 1.12 (0.17 – 7.17) 
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Table 6. Crude, adjusted and imputed estimates for the direct, indirect and total 
effects of the intervention on 30-day PPA at 12-months accounting for potential 
mediators 
  OR (95% CI) 
Mediator  Natural Direct 
Effect 
Natural Indirect 
Effect 
Marginal Total 
Effect 
Quitline or 
local clinic 
program 
use 
(n=250) 
Crude 2.39 (1.04 – 5.47) 0.89 (0.79 – 1.00) 2.12 (0.93 – 4.84) 
Adjusted* 2.53 (1.01 – 6.33) 0.90 (0.80 – 1.02) 2.28 (0.91 – 5.71) 
Multiple 
Imputation 
2.74 (1.06 – 7.03) 0.93 (0.83 – 1.04) 2.54 (1.01 – 6.41) 
NRT use 
(n=250) 
Crude 2.18 (0.96 – 4.96) 0.96 (0.88 – 1.05) 2.10 (0.92 – 4.77) 
Adjusted* 2.36 (0.94 – 5.95) 0.98 (0.90 – 1.06) 2.30 (0.91 – 5.81) 
Multiple 
Imputation 
2.59 (1.01 – 6.59) 0.99 (0.93 – 1.04) 2.55 (1.01 – 6.46) 
Motivation 
to quit 
(n=227) 
Crude 2.40 (0.94 – 6.11) 0.78 (0.35 – 1.75) 1.87 (0.54 – 6.46) 
Adjusted* 2.70 (0.93 – 7.83) 0.85 (0.36 – 1.98) 2.28 (0.58 – 8.96) 
Multiple 
Imputation 
2.36 (0.86 – 6.45) 1.02 (0.66 – 1.57) 2.41 (0.80 – 7.22) 
Self-
efficacy to 
quit 
(n=215) 
Crude 3.22 (0.85 – 12.15) 0.84 (0.49 – 1.44) 2.70 (0.65 – 11.23) 
Adjusted* 2.22 (0.47 – 10.58) 1.35 (0.57 – 15.76) 3.00 (0.57 – 15.76) 
Multiple 
Imputation 
1.88 (0.53 – 6.59) 1.13 (0.95 – 1.35) 2.12 (0.59 – 7.58) 
*Adjusted for baseline confounders race, age, gender, enrollment time, health, 
depression, cpd, nicotine dependence, lifetime quit attempts, previous NRT use, 
motivation to quit and self-efficacy to quit using propensity score methods  
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Table 7. Adjusted 12-month stratified analyses by potential moderators 
12-month 30-day PPA Adjusted OR* (95% CI) Multiple Imputation OR 
(95% CI) 
Gender   
   Female 3.03 (1.63 – 5.62) 2.19 (0.85 – 5.63) 
   Male 1.62 (0.11 – 24.14) 2.00 (0.26 – 15.20) 
Age   
   18–39 4.87 (1.02 – 23.11) 4.82 (0.66 – 35.32) 
   40+ 2.04 (0.97 – 4.27) 1.59 (0.56 – 4.51) 
Race MH-adjusted (pscore) Risk 
Difference 
 
   White/Other 0.0171 (-0.2069 – 0.2412) N/A 
   Hispanic -0.0739 (-0.0288 – 0.1766) N/A 
   Black 0.0922 (-0.0404 – 0.2249) N/A 
Nicotine Dependence   
   Low to Moderate 
Dependence 
1.55 (1.04 – 2.33) 1.36 (0.67 – 2.78) 
   Moderate to High 
Dependence 
4.16 (0.44 – 39.34) 5.97 (0.54 – 65.46) 
Other Smokers in 
Household 
  
   Yes 2.36 (1.21 – 4.58) 1.88 (0.63 – 5.55) 
   No 3.31 (1.29 – 8.47) 3.22 (1.24 – 8.34) 
Perceived Stress   
   High 0.76 (0.31 – 1.85) 0.82 (0.26 – 2.63) 
   Low 5.55 (2.06 – 14.97) 4.28 (1.49 – 12.30) 
Social Support MH-adjusted (pscore) Risk 
Difference 
 
   High 0.0912 (-0.0034 – 0.1857) N/A 
   Low 0.0905 (-0.0966 – 0.2776) N/A 
*Adjusted for baseline confounders race, age, gender, enrollment time, health, 
depression, cpd, nicotine dependence, lifetime quit attempts, previous NRT use, 
motivation to quit and self-efficacy to quit using propensity score methods 
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Table 8. Twelve-month moderation measures on the additive (RERI) and 
multiplicative (ROR) scales for potential mediators 
Potential Moderator Additive Scale RERI 
(95% CI) 
Multiplicative Scale ROR 
(95% CI) 
Gender (female) 2.10 (-1.59 – 5.78) 1.56 (0.26 – 9.48) 
Age (18–39) 0.92 (-1.40 – 3.25) 2.03 (0.20 – 20.78) 
Race N/A N/A 
Nicotine dependence 
(<5) 
-1.98 (-13.49 – 9.54) 0.24 (0.02 – 2.37) 
Perceived stress (low) 1.61 (-0.14 – 3.35) 4.84 (0.85 – 27.64) 
Other smokers in 
household (none) 
0.57 (-2.03 – 3.17) 1.42 (0.40 – 5.04) 
Perceived social support 
(high) 
N/A N/A 
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Table 9. Twelve-month moderation measures on the additive (RERI) and 
multiplicative (ROR) scales for potential mediators using multiple imputation 
procedures 
Potential Moderator Additive Scale RERI 
(95% CI) 
Multiplicative Scale ROR 
(95% CI) 
Gender (female) 1.57 (-1.40 – 4.55) 1.02 (0.14 – 7.13) 
Age (18–39) 0.77 (-1.17 – 2.72) 2.75 (0.34 – 22.37) 
Race N/A N/A 
Nicotine dependence 
(<5) 
-2.69 (-14.86 – 9.49) 0.44 (0.02 – 2.29) 
Perceived stress (low) 1.56 (-0.28 – 3.40) 3.88 (0.80 – 18.91) 
Other smokers in 
household (none) 
0.34 (-1.68 – 2.35) 1.25 (0.37 – 4.17) 
Perceived social support 
(high) 
N/A N/A 
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Figure 2. Distribution of propensity scores for TTA intervention and control groups 
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Figure 3. Directed Acyclic Graph (DAG) illustrating necessary control of C2 when assessing direct effects; where E 
= exposure, D = disease, M = mediator, Ci = confounders 
 
  
6
0
 
Figure 4. DAG illustrating confounding of mediation effect in the case of time-varying mediators and the presence 
of an exposure-induced confounder of the mediator-outcome relationship; where E = exposure, D = disease, Mi = 
mediators, Ci = confounders 
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EXAMINING PREDICTORS OF ATTITUDES TOWARDS NICOTINE 
REPLACEMENT THERAPY  
BACKGROUND 
While nicotine replacement therapy (NRT) is a proven method to help 
smokers successfully quit smoking 97–99, NRT utilization is low among 
socioeconomically disadvantaged smokers.  Among African-Americans the 
prevalence of NRT use ranges from 22–34% and among Latinos ranges from 
22–26% compared with 50% of White smokers7,8.  Although NRT use is low, 
racially and ethnically diverse smokers report similar desire and motivation to quit 
smoking compared to their White counterparts and NRT use could help them 
achieve cessation100.   
Despite the clinical evidence of its benefit, barriers to NRT use in this 
population remain.  While the most common obstacle cited is the perceived high 
cost of NRT98, low rates of NRT use are also often related to inadequate 
knowledge and negative attitudes about the products.  In a qualitative study101 
examining the difficulties of quitting among disadvantaged smokers, participants 
expressed not wearing patches as prescribed, not adhering to recommended 
doses of gum, and not increasing dosage strength with heavier smoking.  In 
addition, smokers were influenced by subjective beliefs of other smokers who 
claimed NRT was ineffective101.  Racial/ethnic minorities in particular are more 
likely to have low levels of knowledge about the functional benefits of 
pharmacotherapy, convey skepticism about the effectiveness of medications, and 
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express concern about side effects of medication compared to the risks of 
smoking22,102,103.  Smokers also report fear of potential side effects and 
inadequate dosage100.  These negative attitudes and lack of knowledge about 
NRT likely contribute to the low prevalence of utilization among 
socioeconomically disadvantaged smokers. 
However, when given access to NRT for smoking cessation, abstinence 
outcomes are similar for racial/ethnic minority groups compared to Whites105.  
When low-income smokers were provided with free NRT, users reported high 
levels of satisfaction with the medication106.  In a study107 that examined the 
effectiveness of a large-scale distribution of NRT patches to predominantly low-
income residents in New York City, NRT users were significantly more likely than 
non-users to quit smoking.   
Given the relatively high rate of smoking in low-income communities2, 
increasing NRT use could help to increase quit rates.  NRT use itself may be 
increased by improving both subjective attitudes and objective knowledge of 
NRT.  Attitudes, perceptions, and beliefs are known predictors of smoking 
cessation behaviors24,25.  Increasing knowledge of NRT, either through physician 
contact or public health interventions, has been shown to lead to greater NRT 
use108.  Exploring predictors of attitudes and knowledge towards NRT in the 
context of a smoking cessation study may help identify changing these attitudes 
and knowledge as a future intervention target that might lead to greater NRT use. 
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As part of the KIG intervention, tobacco treatment advocates encouraged 
use of cessation aids including NRT and connected participants with cessation 
resources where they could access NRT.  Thus, we expect the intervention to be 
associated with an increase in knowledge and positive attitudes about NRT.  
Physician advice is considered an important public health intervention for 
smoking5.  Clinical practice guidelines suggest physicians should communicate 
with their patients the 5 A’s: ask about smoking status, advise patients to quit, 
assess whether patients are ready to quit, assist the patient with quitting, and 
arrange follow-up visits to avoid relapse5.  Among low-income adults, the 
importance of reciprocity in physician communication is emphasized109.  Thus, 
we expect both patient-initiated and doctor-initiated discussion of ways to quit 
smoking to be associated with an increase in knowledge and positive attitudes 
about NRT. 
The aim of the current study was to determine if the intervention and 
communication with a physician as well as NRT use itself predict change in 
attitudes and knowledge of NRT at each follow-up and across the study period.  
We hypothesized that the assigned intervention group and self-reported 
communication with the doctor (patient-initiated and doctor-initiated) and NRT 
use during the intervention will be associated with an increase in attitudes and 
knowledge of NRT from baseline to follow-up.   
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METHODS 
 
Design  
 
The current study design was a prospective cohort using participants from 
the KIG study.  Among the main predictors, participants were randomized to 
intervention or control group at baseline while other variables of interest 
(discussing ways to quit smoking, discussing NRT to quit smoking, and NRT use) 
were not randomized.  Therefore, although the parent KIG study was a group-
randomized control trial, the current study design is considered to be a 
prospective cohort.   
Participants 
The analytic sample was composed of participants who were enrolled at 
baseline and had at least one visit with their TTA (n=331).  Analyses were 
conducted for each 3-month, 7-month, and 12-month follow-up among 
participants who completed the relevant follow-up.  Multiple imputation was also 
used to account for loss to follow-up at 3, 7, and 12-months.   
Exposure Measurement 
 
Four predictors of change in attitudes towards nicotine therapy were examined:  
(1) KIG intervention- group assignment in the KIG study: motivational 
interviewing-based intervention or standard control. 
(2) Participant self-report of whether or not they discussed general methods 
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of quitting smoking with their doctor (either initiated by the doctor or 
themselves) and this was measured at baseline, 3 and 7-month follow-
ups. 
(3) Participant self-report of whether or not they discussed using NRT to quit 
smoking with their doctor (either initiated by the doctor or themselves) and 
this was measured at 3 and 7-month follow-up only. 
(4) Participant self-report of NRT use defined as use of any nicotine 
replacement therapy products (patches, gum, lozenges, inhaler, or nasal 
spray) between baseline and follow-up. 
Outcome Measurements 
Knowledge and attitudes towards smoking cessation medications were 
measured by a modified version of the Attitudes Toward Nicotine Replacement 
Therapy (aNRT) Scale110, a 12-item scale which measures objective knowledge 
and subjective attitudes of NRT by assessing participant’s perceptions of 
functional advantages (e.g., reducing withdrawal symptoms, an aid in quitting) 
and disadvantages (e.g., side effects, risk of dependence) of NRT.  Total aNRT 
scores ranged from 0–60 with higher scores indicating greater knowledge and 
more positive attitudes towards nicotine replacement therapy. 
In addition to assessing the total aNRT scale score as an outcome, the 
aNRT attitude sub-scale score and knowledge sub-scale score were considered 
as additional outcomes.  The knowledge sub-scale was composed of the six 
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items pertaining to objective NRT knowledge.  These items were scored as the 
number of correct answers out of six items.  A correct answer was indicated by a 
response of “Fully agree” or “Generally agree”.  Responses of “More or less 
agree”, “Do NOT really agree”, “Strongly disagree” or “Don’t know” were scored 
as incorrect answers.  Higher number of correct answers indicated greater 
knowledge about NRT.  The attitude sub-scale was composed of the six items 
pertaining to subjective attitudes towards NRT.  These items were scored 
similarly to the full aNRT scale where total scores ranged from 0–30 and higher 
scores indicated more positive attitudes towards smoking cessation medication.   
Covariates 
 
Potential covariates included age (18–39 vs. 40+), sex (female vs. male), 
race (White, Black, Hispanic), and education (less than high school, high school 
graduate and college graduate).  Smoking and health characteristics assessed 
were cigarettes per day (≤10 vs. 11+), Fagerstrom Test for Nicotine Dependence 
(FTND) score (≤4 vs. 5+)58, NRT use (patches, gum, lozenges, inhaler, nasal 
spray) in the past 12 months, know somebody who used NRT, seen regular 
primary care physician (PCP) in the past 12 months, health status (excellent/very 
good vs. good/fair/poor), and depression (dichotomized based on CESD-10 
score)111.  Motivation to quit was assessed by the “Readiness to Quit Ladder”56, a 
10-point ordinal measure of motivation with respect to readiness to quit smoking.  
Responses ranged from “1-I have no interest in quitting” to “10-I have quit 
smoking”.  Enrollment time into the study (3/31/2012 or earlier, 4/1/2012–
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9/30/2012, 10/1/2012 or later) was used as a potential covariate, because a 
smoking ban was implemented in all Boston public housing units beginning 
October 1, 2012.  The enrollment time variable was meant to proxy a dose-
response effect where participants recruited temporally closer to the ban might 
have been more likely to think about quitting and those recruited after the ban 
was implemented would be most likely to quit.   
Model Building 
 
Crude means and distributions of relevant baseline variables were 
examined by intervention status to determine potential covariates.  Directed 
acyclic graphs (DAGs) of the relationships between the intervention, aNRT, and 
potential covariates were constructed using theoretical knowledge, the literature, 
and descriptive statistics.  A generalized linear model (GLM) was used to 
calculate the crude association between the intervention and aNRT for 
comparison to adjusted estimates.  Since propensity scores allow for more 
efficient control of a larger number of potential covariates than the number of 
outcomes would generally allow62, a propensity score model which predicted 
intervention status was constructed using all potential covariates.  These 
covariates were race, previous NRT use, enrollment time, nicotine dependence, 
depression, gender, motivation to quit, regular PCP, age, health status, 
cigarettes per day, education, and seen PCP within past 12 months.  Propensity 
score distributions were compared between intervention and control groups to 
ensure sufficient overlap (Figure 5) and the propensity score values were 
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included as an individual covariate in the final aNRT models.   
Statistical Analysis 
        Generalized linear models were used to predict the total aNRT scale 
score, knowledge sub-scale score, and attitudes sub-scale score at each time 
point for the intervention and other relevant predictors, including discussion with 
doctor of ways to quit smoking, discussion with doctor of NRT to quit smoking 
and NRT use.  Models used an identity link to estimate absolute values of the 
scores and a normal distribution for all continuous outcomes.  For each model, 
adjustment was made for propensity score, baseline score of the outcome 
variable, and baseline status of the predictor variable where appropriate (e.g. 
discussed ways to quit with doctor at baseline where predictor is 3/7/12-month 
discussion of ways to quit with doctor).  Additionally, for predictors that were not 
randomized at baseline, models were adjusted for intervention group.  Models 
also accounted for within-site correlation using a compound symmetry structure. 
Mean adjusted scores were calculated from the model using an LSMEANS 
statement.  
Hierarchical linear modeling (HLM) was used to predict the total aNRT 
scale score, knowledge sub-scale score, and attitudes sub-scale score across 
the study period for the intervention only. This method allowed for the 
assessment of the effect of the intervention on aNRT outcomes at each time 
point and across all time points, regardless of individual survey completion 
patterns.  The utility of HLM also allowed for accounting of repeated measures by 
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subject and within-site correlation from the randomization procedures.   
Multiple Imputation 
 
To account for potential bias due to loss to follow-up, multiple imputation 
procedures were used to impute missing aNRT outcomes.  Using Markov chain 
Monte Carlo (MCMC) simulation procedures, total aNRT scale scores, 
knowledge sub-scale scores, and attitude sub-scale scores at each 3, 7 and 12-
month follow-up were predicted from variables known in this study to predict 
missingness: race, enrollment time, previous NRT use, depression and nicotine 
dependence.  A total of n=10 imputed datasets were created and analyzed using 
the PROC MI procedure in SAS v9.4.   
RESULTS 
 
Demographic, Health and Smoking Characteristics 
 
Of the 331 smokers who enrolled in the study and had at least one visit 
with a TTA, n=240 participants completed the 3-month follow-up questionnaire, 
n=250 completed the 7-month follow-up questionnaire, and n=250 participants 
completed the 12-month follow-up questionnaire. 
At baseline, participants were mostly female (72%) and greater than age 
40 (68%) (Table 10).  The distribution of race/ethnicity was 56% Black, 25% 
Hispanic and 19% White/Other.  While 48% had a high school diploma or 
equivalent, 29% had less than a high school education.   
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Fifty-nine percent reported they were in Good, Very Good or Excellent 
health.  Participants reported high contact rates with the health care system; 93% 
had a regular primary care physician (PCP) and 89% saw that PCP within the 
last year.  Based on the CES-D-10, 39% of participants screened positive for 
depression. 
A majority (57%) of participants smoked less than 10 cigarettes per day 
and 63% were classified as having low to moderate dependence on nicotine 
based on the Fagerstrom Test for Nicotine Dependence.  About half (51%) of 
participants knew someone who used NRT and 47% had previously used NRT 
themselves.   
Total aNRT score 
 
3-month follow-up 
 
 At 3-month follow-up, NRT use was significantly associated with total 
attitudes towards NRT scores (Table 11).  Those who used NRT between 
baseline and 3-month follow-up had a mean adjusted score of 38.54 (95%CI: 
36.25 – 40.83) on the attitudes towards NRT scale while those who did not use 
NRT had a mean adjusted score of 29.96 (95%CI: 28.75 – 31.17).  This indicates 
that more recent NRT users had more positive attitudes and greater knowledge 
of NRT.  Discussing ways to quit with a doctor between baseline and 3-month, 
both generally and specifically about NRT, were also associated with higher total 
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aNRT scores.  Notably, the intervention was not a significant predictor of overall 
aNRT scores at 3-months. 
7-month follow-up 
 
 At 7-month follow-up, after the completion of the intervention period, NRT 
use, discussing NRT use to quit with a doctor, and discussing ways to quit with a 
doctor were associated with total aNRT scores (Table 11).  Among those who 
used NRT between baseline and 7-months, mean adjusted total aNRT score was 
36.99 (95%CI: 34.24 – 39.74) and among those who did not use NRT was 27.63 
(95%CI: 26.63 – 28.63).  Among those who discussed general ways to quit with 
their doctor between baseline and 7-month, mean adjusted total aNRT score was 
31.99 (95%CI: 29.93 – 34.05), and 27.16 (95%CI: 24.87 – 29.45) for those who 
did not discuss with their doctor.  For those who specifically discussed NRT to 
quit with their doctor between baseline and 7-month, mean adjusted total aNRT 
score was 34.67 (95%CI: 32.85 – 36.49) and for those who did not discuss NRT 
to quit, mean adjusted score was 26.84 (95%CI: 25.30 – 28.38).   
12 month follow-up 
 
 At 12-month follow-up, the final assessment point in the KIG study, NRT 
use and discussion of both ways to quit and NRT to quit with a doctor between 
baseline and 12-month were significantly associated with total attitudes towards 
nicotine replacement therapy (Table 11).  The mean adjusted total aNRT score 
for those who used NRT at any point in the study period was 36.13 (95%CI: 
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32.94 – 39.32), and 26.51 (95%CI: 23.82 – 29.20) for those who did not use 
NRT.  Among those who discussed ways to quit with their doctor between 
baseline and 12-month, mean adjusted score was 31.69 (95%CI: 28.90 – 34.48), 
and among those who did not discuss ways to quit with their doctor was 24.88 
(95%CI: 21.93 – 27.83).  Similarly, among those who discussed using NRT to 
quit with their doctor between baseline and 12-month, mean total aNRT score 
was 33.68 (95%CI: 31.10 – 36.26) and was 25.39 (95%CI: 22.62 – 28.16) for 
those who did not discuss using NRT to quit with their doctor. 
Adjusted means and 95% confidence intervals for total aNRT scores at 
each follow-up are presented for the intervention (Table 12), NRT use (Table 13), 
discussion of ways to quit with the doctor (Table 14), and discussion of NRT to 
quit with the doctor (Table 15).   
NRT Knowledge sub-scale score 
 
3-month follow-up 
 
 NRT use, discussing ways to quit with a doctor and discussing NRT to quit 
with a doctor were all associated with knowledge about NRT at 3-month follow-
up (Table 16).  The mean adjusted knowledge score among those who used 
NRT between baseline and 3-months was 2.99 (95%CI: 2.54 – 3.44) while it was 
2.08 (95%CI: 1.86 – 2.30) for those who did not use NRT.  Among those who 
discussed ways to quit with their doctor between baseline and 3-month, the 
mean adjusted knowledge score was 2.55 (95%CI: 2.31 – 2.79), and among 
 73 
those who did not discuss ways to quit with their doctor the score was 2.15 
(95%CI: 1.90 – 2.40).  Similarly, among those who discussed NRT to quit with 
their doctor between baseline and 3-month, mean adjusted knowledge score was 
2.69 (95%CI: 2.34 – 3.04), and among those who did not discuss the score was 
2.14 (95%CI: 1.92 – 2.36). 
7-month follow-up 
 
 NRT use and discussion of NRT to quit with a doctor were also 
significantly associated with knowledge about NRT at 7-month follow-up (Table 
16).  Among those who used NRT to quit, mean adjusted knowledge score was 
2.71 (95%CI: 2.10 – 3.32) and among those who did not use NRT to quit, mean 
adjusted knowledge score was 1.87 (95%CI: 1.67 – 2.07).  Knowledge scores 
were also higher for those who discussed using NRT to quit with their doctor 
(2.47, 95%CI: 1.98 – 2.96) between baseline and 7-month versus those who did 
not discuss (1.83, 95%CI: 1.65 – 2.01). 
12-month follow-up 
 
 At 12-month follow-up, NRT use and discussion of both ways to quit and 
NRT to quit with a doctor were associated with knowledge about NRT (Table 16).  
Among NRT users, mean adjusted knowledge score was 2.59 (95%CI: 2.10 – 
3.08), and 1.59 (95%CI: 1.23 – 1.95) among non-users.  For those who 
discussed ways to quit with their doctor between baseline and 12-month, mean 
adjusted score was 2.09 (95%CI: 1.70 – 2.48), and 1.45 (95%CI: 1.03 – 1.87) 
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among those who did not discuss ways to quit with their doctor.  Among those 
who discussed using NRT to quit with their doctor between baseline and 12-
month, mean adjusted knowledge score was 2.43 (95%CI: 2.06 – 2.80), and 1.42 
(95%CI: 1.02 – 1.82) among those who did not discuss using NRT to quit with 
their doctor. 
Adjusted means and 95% confidence intervals for NRT knowledge scores 
at each follow-up are presented for the intervention (Table 17), NRT use (Table 
18), discussion of ways to quit with the doctor (Table 19), and discussion of NRT 
to quit with the doctor (Table 20).   
NRT Attitudes sub-scale score 
 
3-month follow-up 
 
 At 3-month follow-up, NRT use since baseline was associated with 
attitudes towards NRT (Table 21).  Among those who used NRT, the adjusted 
mean score was 19.84 (95%CI: 18.53 – 21.15), while it was 16.03 (95%CI: 15.25 
– 16.81) among those who did not use NRT. 
7-month follow-up 
 
 NRT use was associated with NRT attitudes (Table 21) and were more 
positive among those who used NRT (18.99, 95%CI: 17.33 – 20.65) than those 
who did not (14.82, 95%CI: 14.05 – 15.59) between baseline and 7-month follow-
up.  Among those who discussed using NRT to quit with their doctor between 
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baseline and 7-month, mean adjusted knowledge scores were also higher 
(17.66, 95%CI: 16.60 – 18.72) than those who did not discuss with their doctor 
(14.74, 95%CI: 13.84 – 15.64). 
12-month follow-up 
 
NRT use was associated with NRT attitudes at 12-month follow-up (Table 
21).  Among NRT users, mean adjusted attitude score was 19.31 (95%CI: 17.92 
– 20.70), and 14.53 (95%CI: 13.26 – 15.80) for non-users.  For those who 
discussed ways to quit with their doctor between baseline and 12-month, mean 
adjusted attitude score was 17.18 (95%CI: 15.93 – 18.43), and 13.65 (95%CI: 
12.25 – 15.05) for those who did not discuss ways to quit with their doctor.  
Among those who discussed using NRT to quit with their doctor between 
baseline and 12-month, mean adjusted score was 17.96 (95%CI: 16.58 – 19.34), 
and 14.04 (95%CI: 12.79 – 15.29) among those who did not discuss using NRT 
to quit with their doctor.   
Adjusted means and 95% confidence intervals for NRT attitude scores at 
each follow-up are presented for the intervention Table 22), NRT use (Table 23), 
discussion of ways to quit with the doctor (Table 24), and discussion of NRT to 
quit with the doctor (Table 25).   
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Intervention Effect across the Study Period 
 
Total aNRT scale score 
 
 Across the study period, the intervention was not a significant predictor 
(p=0.21) of total attitudes toward and knowledge of nicotine replacement therapy 
(Table 26).  Interestingly, after an initial increase in scores between baseline and 
3-months, aNRT scores were decreased at the 7-month and 12-month follow-up 
assessments.  From baseline to the end of the study, aNRT scores decreased by 
0.54 in the intervention group and 3.25 in the control group (Table 27).   
NRT Knowledge sub-scale score 
 
 Across the study period, the intervention did not predict knowledge about 
nicotine replacement therapy (Table 28).  Knowledge scores were highest for 
both the intervention and control groups at 3-month follow-up and were 
decreased at both the 7-month and 12-month follow-up assessments (Table 29).  
From baseline to the end of the study, knowledge scores increased by 0.28 in the 
intervention group and decreased by 0.34 in the control group. 
NRT Attitudes sub-scale score 
 
 Across the study period, the intervention did not impact attitudes towards 
nicotine replacement therapy (p=0.26) (Table 30).  Overall attitude scores 
decreased across the follow-up assessments with the highest scores for both the 
intervention and control groups seen at 3-month follow-up (Table 31).  From 
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baseline to the end of the study, attitude scores decreased by 1.17 in the 
intervention group, and decreased by 1.78 in the control group. 
Multiple Imputation for Intervention as a Predictor Only 
 
 Multiple imputation results suggest complete-case analysis results were 
robust (Table 32).  There was no effect of the intervention on total aNRT score, 
knowledge sub-scale score, nor attitudes sub-scale score at neither the 3-month, 
7-month, nor 12-month follow-up assessments. 
DISCUSSION 
Findings on Total Attitudes and Knowledge of NRT at Follow-Up 
Overall attitudes towards nicotine replacement therapy were not affected 
by the KIG intervention at any point in the study.  This result is interesting as the 
intervention itself did not aim specifically to increase attitudes and knowledge of 
NRT.   However, TTAs who provided the MI intervention encouraged NRT use as 
a smoking cessation aid and this predicted overall aNRT at each follow-up.   
To our knowledge, few studies have examined the effect of NRT use on 
changing attitudes and knowledge of the product, especially over time.  In a small 
study of general population smokers by Mooney, et al.112, perceived advantages 
of NRT were higher among those who had previously used NRT.  While it may 
be evident that using NRT would predict more positive beliefs about these 
products, it is encouraging nonetheless that NRT use had a positive impact on 
attitudes and knowledge in this low-income population.  Misperceptions about 
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NRT are prevalent among racially and ethnically diverse smokers even for 
previous NRT users with mistrust in development and regulation by 
manufacturing companies, wariness about safety and efficacy, and overall cost-
benefit to smokers all cited as potential barriers to NRT use23.  Our study showed 
these misperceptions can be mitigated and are modifiable by experiences of 
NRT use.  Thus, while the KIG intervention did not directly impact overall aNRT, 
increased NRT use was a function of the intervention and NRT use itself 
significantly improved attitudes and knowledge of the product.  Our findings are 
clinically applicable in the sense that initial resistance to NRT use because of 
negative attitudes or lack of knowledge should be overcome with continued 
encouragement to use NRT as this may have positive aNRT outcomes that may 
facilitate cessation.    
On the other hand, we cannot be entirely certain that the direction of the 
association in our sample was that NRT use caused the observed changes in 
attitudes towards NRT.  We considered NRT use at each time point as self-report 
of any use of the products since baseline.  Attitudes towards NRT was measured 
via questionnaire at each time point.  This operationalization of the variables 
ensured NRT use was precedent to aNRT.  Nevertheless, it could be that the 
intervention or unmeasured factors which we were unable to capture, such as 
anecdotal experience from a friend, influenced attitudes at a prior time point and 
this change in attitude affected subsequent NRT use and consequently our later 
capture of aNRT (Figure 6).  While our results indicate NRT use was associated 
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with aNRT at each time point, it is more plausible to believe that a change in 
attitude occurred prior to NRT use.  Thus, our conclusions on the effect of NRT 
use on aNRT are severely limited by the lack of temporal clarity in these 
measurements.   
Discussion of general ways to quit with a doctor and specifically NRT to 
quit with a doctor predicted total attitudes towards NRT at 3-month, 7-month and 
12-month follow-up and this effect increased over time.  These results are 
promising, because the barriers to NRT use in low-income populations are multi-
faceted and complex, but our study shows a simple physician conversation is an 
alternative, low-intensity solution that improves aNRT and may lead to increased 
NRT use.  Our results are also similar to other studies which show expert 
healthcare advice is associated with positive health outcomes, especially for low-
income patients113–115.  Particularly, among African-American smokers there is a 
strong trust in physicians to provide health information and advice23.  
Furthermore, engagement with the healthcare system was high in our study 
population with 93.4% reported having a primary care physician at baseline and 
88.5% reporting that they saw their physician in the last year.  Thus, encouraging 
physicians to discuss cessation with their patients could increase access to 
smoking cessation resources in this population.  Physicians should also speak 
more in-depth about NRT as a quit method as the effect of discussing NRT 
specifically to quit with a doctor was greater than the effect of discussing general 
ways to quit with a doctor on associated attitudes and knowledge.  In sum, our 
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results suggest similar to other studies113,116–118 that healthcare providers for low-
income populations should be trained and educated about how to inform and 
engage their smoking patients about cessation methods, especially NRT. 
Finally, when analyzing the total aNRT sub-scales of knowledge and 
attitudes as separate outcomes, results were analogous to the total aNRT 
outcome results.  That is, the intervention was not a significant predictor of either 
NRT knowledge or attitudes over the study period.  NRT use significantly 
predicted higher knowledge and attitude scores versus those who did not use 
NRT at each follow-up.  Discussion of general ways to quit and specifically NRT 
to quit also predicted both knowledge and attitude outcomes at each follow-up.  
Greater effects of discussion with a physician were seen with longer follow-up 
and discussion of NRT specifically had a greater effect than discussion of 
general ways to quit.  The similarity of these subscale results to the total scale 
results suggests the effects of the significant predictors on total aNRT were not 
driven by increases solely in attitudes or knowledge alone, but an increase in 
both objective and subjective beliefs.  In a socioeconomically disadvantaged 
population where education levels are low and susceptibility to anecdotal 
misinformation is high22,102,103, it is encouraging that both knowledge and 
attitudes about efficacious nicotine replacement therapy medications can be 
improved.   
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Findings on the Effect of the KIG Intervention on Total aNRT across the 
Study Period 
We examined the effect of the Kick it for Good intervention on attitudes 
and knowledge of NRT accounting for the multiple follow-up assessments across 
the study period.  Similar to the analyses examining outcomes at each follow-up 
assessment alone, there was no effect of the KIG intervention on changing total 
attitudes and knowledge of NRT nor each of the subscales over the course of the 
study.  Interestingly, the mean total aNRT scores for the intervention group were 
lower than the control group at the 3-month and 7-month follow-up.  Although, 
total aNRT scores in both groups decreased from baseline to 12-month follow-up 
and the decrease was less for the intervention than the control group.  Similar 
results were seen for both the knowledge and attitudes subscales. 
It is interesting that attitudes and knowledge of NRT did not improve as a 
result of the KIG intervention over time.  Although the intervention itself did not 
directly target a change in these beliefs, there was increased NRT use as a result 
of the intervention and this predicted changes in aNRT.  Additionally, TTAs 
provided information about NRT which may have helped increase knowledge and 
TTAs discussed barriers and concerns about NRT use which may have 
enhanced attitudes.  Moreover, the implication that overall attitudes and 
knowledge of NRT were reduced across the study period even after controlling 
for baseline measures is noteworthy.  Given the literature on how beliefs 
influence smoking behavior change24,25, future smoking cessation interventions 
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should ensure its impact on attitudes and knowledge of NRT is, if not helpful, at 
least not harmful.   
One reason for the lack of intervention effect may be due to the varying 
number of TTA visits among intervention participants.  When examining 
knowledge outcomes at the 12-month follow-up by the number of TTA visits 
among those in the intervention group with three or more visits, overall 
knowledge scores were higher (2.11) than for those in the intervention group with 
only one or two visits (1.60), and higher than the control group (1.68).  However, 
analyses of total aNRT outcomes and attitude only outcomes by number of TTA 
visits showed higher scores for those in the intervention group with 3 or more 
TTA visits than for those with only one or two, but these scores were still lower 
than the control group.  Thus, while the intervention may have had an effect on 
knowledge outcomes over time for those with more TTA visits, there was still no 
effect of the intervention on total aNRT or on attitudes alone.   
Another reason for the lack of intervention effect on attitudes and 
knowledge of NRT across the study period may be due to the waning effect of 
the intervention after the active intervention period was complete.  There is a 
distinct increase in knowledge scores for both the intervention and control groups 
from baseline to 3-month follow-up, but a steady return to baseline and in fact a 
decrease for the control group by 12-month follow-up.  It could be that the 
intervention itself was impactful on knowledge of NRT, but the increase in 
knowledge was sensitive to the recent intervention visits.  The active intervention 
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period was completed by six months post-baseline and lower knowledge scores 
are seen thereafter at 7-month and 12-month follow-up.  Thus, the TTA 
intervention effect on subjective knowledge is evident in close proximity to the 
intervention delivery, but this effect is obscured when examining outcomes of 
overall aNRT across the study period.   
 In an effort to explain the lack of intervention effect on aNRT, we 
examined post-hoc the effect of the intervention on individual aNRT items, but 
found no specific items that were significantly impacted by the intervention.  
Given the impact of NRT use but not the intervention on aNRT, we also explored 
a post-hoc counterfactual mediation analysis of NRT use at 3-months as a 
mediator of the intervention-aNRT association.  Interestingly, the direct effect of 
the intervention was to decrease aNRT scores (β = -1.44 (-4.50 – 1.62) and the 
effect mediated by NRT was to increase aNRT scores (β = 0.59 (-0.72 – 1.89).  
The marginal total effect was a linear combination of the direct and indirect 
effects (β = -0.85 (-5.84 – 4.13).  Although the point estimates suggest a 
potentially true negative effect of the intervention on aNRT, the widths of these 
confidence intervals are imprecise to such a degree that it is difficult to discern 
whether the intervention effect is negligible or undetectable in this study.  
Interestingly, the indirect effect gives further evidence that the pathway through 
which the intervention impacted aNRT was via NRT use.  It is encouraging that 
perhaps the intervention was able to push users beyond their initial negative 
attitudes on NRT to facilitate use of the products.   
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 In sum, there are two main implications of our findings on predictors of 
attitudes and knowledge of nicotine replacement therapy in a public housing 
sample that may be relevant for future smoking intervention studies in 
socioeconomically disadvantaged populations.  First, there is value in engaging 
healthcare providers to offer expert advice on nicotine replacement therapy.  
Access to the healthcare system is relatively high in this population and so reach 
of an intervention that utilizes this existing infrastructure could also be high.  
Many healthcare providers are already trained in delivering smoking cessation 
advice and so additional tailoring of messages towards low-income and 
ethnically/racially diverse smokers would require minimal investment of further 
resources.  Second, there remains the issue of whether changes in attitudes and 
knowledge of NRT precedes or results from NRT use.  Due to the lack of 
temporal clarity, the association between NRT use and aNRT is evident although 
not its direction.  If changes in aNRT lead to NRT use then increasing knowledge 
and positive attitudes is a relevant intervention target since NRT use is known to 
help smokers quit.  If NRT use leads to changes in aNRT, although it is 
encouraging that perhaps initial negative attitudes can be overcome with NRT 
use, these results seem less applicable if NRT use is already occurring.  To 
determine if this is a relevant pathway to increasing quit rates among 
socioeconomically disadvantaged smokers, future intervention studies should 
directly examine whether changes in aNRT predict cessation via NRT use.   
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Strengths and Limitations 
 
 There were limitations of this study due to the use of data from the Kick it 
for Good trial.  First, randomization of the KIG study was at the level of the group 
and not the individual.  Due to the small number of public housing sites 
randomized (n=26), we did not have a balance of individual-level characteristics 
between the intervention and control groups.  Thus, potential confounding had to 
be sufficiently controlled through the use of propensity scores.  Also, we 
examined other predictors of attitudes and knowledge of NRT besides the 
intervention, including NRT use and discussion of smoking cessation methods 
with the doctor.  Since these variables were not randomized, sufficient control for 
confounding was also necessary to ensure minimal bias from imbalanced 
individual characteristics.  Finally, we were limited by the survey questions 
available in the KIG study for analysis.  At each follow-up survey, participants 
were asked both whether they had discussed general ways to quit with their 
physician and also whether they had specifically discussed using NRT to quit 
with their physician.  However, at baseline participants were only asked about 
their history of discussing general ways to quit with their physician.  This 
inconsistency in survey questions was problematic, because we could not control 
for discussing NRT to quit with a doctor at baseline.  However, we did control for 
discussing general ways to quit with a doctor at baseline, which would at least 
reduce some of the residual confounding by patients who had a history of 
discussing NRT with their doctor.  
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There were also limitations of this study due to its design.  The temporality 
of the predictor variables was difficult to establish given the lack of detailed time 
resolution between follow-up surveys.  While group assignment was clearly 
precedent to aNRT assessments at follow-up, NRT use and discussion of 
cessation methods with a doctor were measured at the same follow-up as aNRT.   
While it is more likely that discussion with the doctor about cessation methods 
preceded a change in aNRT since report of these variables were asked in 
retrospect, i.e. “Since the last survey, did you discuss using NRT to quit with your 
doctor?”, it is also plausible that change in aNRT due to external factors not 
analyzed in our study could have prompted a discussion with the doctor.  NRT 
use itself is also likely precedent to aNRT due to the operationalization of the 
variables (self-report of ever use across the study period), although it is still more 
plausible that change in aNRT led to consequent NRT use.  
Another limitation of the study design was in the analysis of predictors of 
aNRT at each follow-up.  Because these analyses were conducted separately, 
data were not from the same cohort of individuals at each time point.  Thus, 
comparison of predictor effects across time are not necessarily comparable.  
Additionally, a low number of participants who completed all follow-up surveys 
(n=157) was not sufficient to power analyses across time.  To circumvent the 
issue of inconsistent cohorts for the effect of the intervention, we examined the 
effect of group assignment on aNRT outcomes using hierarchical linear 
modeling, which allows for the use of data from each individual independent of 
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their survey completion patterns across the study period.  The results of this 
analysis across time were congruent with the results of each individual time point 
where there was no effect of the intervention on aNRT.  Unfortunately, we could 
not analyze the effect of the other predictors on aNRT across the study period, 
because in contrast to group assignment, NRT use and discussion of cessation 
methods with the doctor were time-varying variables.  Thus, conclusions on the 
effects of these variables over time should be interpreted cautiously as the cohort 
for analysis differed at each time point.   
Other sources of bias were likely minimal in this study.  Confounding was 
found to be sufficiently controlled through the use of propensity scores.  Given 
the different cohorts of analysis at each time point and the stronger effects seen 
at longer follow-up, it plausible to believe selection bias played a role.  However, 
it is more likely that the increased financial incentive offered at 12-month follow-
up increased motivation to complete the final survey and not that participation 
was affected by changing attitudes and knowledge of NRT.  Also, the multiple 
imputation results were highly similar to the complete case analysis so selection 
bias due to loss to follow-up was likely minimal.  We did not find differential 
participation rates at 12-month follow-up by number of TTA visits so results were 
also not influenced by the intensity of the TTA intervention.  Finally, 
misclassification of the predictor variables was unlikely given that group 
assignment was randomized and self-report in low-income populations is shown 
to be valid and reliable for a variety of health variables119–121.   
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Future Research Directions 
 A major limitation of our study was the lack of established temporality for 
the predictor and outcome variables.  Future studies should delineate clear time 
resolutions for study variables either with baseline assessment and prospective 
follow-up or ecological momentary assessment.  Additionally, it would have been 
interesting to identify specific concerns about NRT in this public housing 
population in order to more accurately tailor intervention approaches to improve 
attitudes and knowledge of NRT.  Qualitative studies99 could examine specific 
concerns and barriers, including safety, side effects, potential for addiction, 
pharmaceutical company ownership, and acceptability of NRT versus other quit 
methods (cold turkey, medications such as Chantix, hypnosis, religion, etc.)  
Finally, the intent of assessing predictors of attitudes and knowledge of nicotine 
replacement therapy was to identify targets that may eventually lead to increased 
NRT use.  Although the KIG study was not designed to test this relationship, 
future studies should examine whether changing attitudes and knowledge of NRT 
is associated with increased NRT use in socioeconomically disadvantaged 
populations.  
Conclusion 
Negative attitudes and lack of knowledge are often cited as barriers to 
NRT use for low-income and racially/ethnically diverse smokers.  Our study 
indicates attitudes and knowledge of NRT can be improved by engaging in 
patient-initiated or provider-initiated discussions about methods of quitting 
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smoking, especially NRT.  NRT use itself was also associated with greater 
attitudes and knowledge of NRT, although a more clear time resolution of our 
study variables would lend greater credence to the direction of this association.  
This study contributes to the literature on attitudes towards nicotine replacement 
therapy in socioeconomically disadvantaged populations, especially as there is 
only one other smoking study122 that we know of that uses this scale to assess 
attitudes and knowledge of NRT.  Future studies should also examine whether 
changes in attitudes and knowledge of NRT predicts increased NRT use and 
consequently smoking cessation. 
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Table 10. Baseline demographic, health and smoking characteristics of KIG 
sample (n=331) 
 Total Sample 
(n=331) 
n (%) 
Intervention 
(n=161) 
n (%) 
Control  
(n=170) 
n (%) 
Age 
   18–39 
   40+ 
 
106 (32.0) 
225 (68.0) 
 
65 (40.4) 
96 (59.6) 
 
41 (24.1) 
129 (75.9) 
Sex 
   Female 
   Male 
 
239 (72.2) 
92 (27.8) 
 
46 (28.6) 
115 (71.4) 
 
46 (27.1) 
124 (72.9) 
Race 
   Hispanic 
   Black 
   White/Other 
 
84 (25.4) 
183 (55.3) 
64 (19.3) 
 
42 (26.1) 
75 (46.6) 
44 (27.3) 
 
42 (24.7) 
108 (63.5) 
20 (11.8) 
Education 
   Less than high school 
   High school or equivalent 
   Some college 
   College graduate 
 
97 (29.3) 
158 (47.8) 
56 (16.9) 
20 (6.0) 
 
45 (28.0) 
74 (46.0) 
31 (19.3) 
11 (6.8) 
 
52 (30.6) 
84 (49.4) 
25 (14.7) 
9 (5.3) 
Health 
   Fair/Poor 
   Good/Very Good/Excellent 
 
136 (41.1) 
195 (58.9) 
 
58 (36.0) 
103 (64.0) 
 
78 (45.9) 
92 (54.1) 
Regular PCP 
   Yes 
   No 
 
309 (93.4) 
22 (6.7) 
 
149 (92.6) 
12 (7.5) 
 
160 (94.1) 
10 (5.9) 
Seen PCP in past 12 months 
   Yes 
   No 
 
293 (88.5) 
38 (11.5) 
 
141 (87.6) 
20 (12.4) 
 
152 (89.4) 
18 (10.6) 
CES-D-10 depression 
   Yes 
   No 
 
130 (39.3) 
201 (60.7) 
 
75 (46.6) 
86 (53.4) 
 
55 (32.4) 
115 (67.7) 
Cigarettes per day 
   ≤10 
   11+ 
 
189 (57.1) 
142 (42.9) 
 
87 (54.0) 
74 (46.0) 
 
102 (60.0) 
68 (40.0) 
Fagerstrom Test for Nicotine 
Dependence* 
   ≤4 (low to moderate) 
   5+ (moderate to high) 
 
 
207 (62.7) 
123 (37.3) 
 
 
102 (63.8) 
58 (36.3) 
 
 
105 (61.8) 
65 (38.2) 
NRT use past 12 months 
   Yes 
   No 
 
155 (46.8) 
176 (53.2) 
 
72 (44.7) 
89 (55.3) 
 
83 (48.8) 
87 (51.2) 
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 Total Sample 
(n=331) 
n (%) 
Intervention 
(n=161) 
n (%) 
Control  
(n=170) 
n (%) 
Know someone who used 
NRT 
   Yes 
   No 
 
 
169 (51.1) 
162 (48.9) 
 
 
81 (50.3) 
80 (49.7) 
 
 
88 (51.8) 
82 (48.2) 
Motivation to quit  
   Low (1–3) 
   Medium (4–6) 
   High (7–10) 
 
9 (2.7) 
63 (19.0) 
259 (78.3) 
 
128 (79.5) 
31 (19.3) 
2 (1.2) 
 
131 (77.1) 
32 (18.8) 
7 (4.1) 
Enrollment time 
   10/1/2012 or later 
   4/1/2012–9/30/2012 
   3/31/2012 or earlier 
 
143 (43.2) 
122 (36.9) 
66 (19.9) 
 
64 (39.8) 
69 (42.9) 
28 (17.4) 
 
79 (46.5) 
53 (31.2) 
38 (22.4) 
Total aNRT Scale 
   Mean (SD) 
 
30.6 (12.7) 
 
29.8 (13.0) 
 
31.3 (12.4) 
Knowledge Sub-scale 
   Mean (SD) 
 
1.8 (1.9) 
 
1.7 (2.0) 
 
2.0 (1.8) 
Attitude Sub-scale 
   Mean (SD) 
 
17.0 (6.1) 
 
16.9 (6.2) 
 
17.1 (6.1) 
*Missing n=1 
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Table 11. Association between predictors and total aNRT score for 3, 7, and 12-month follow-up 
  Intervention NRT use Discussed ways to 
quit with doctor 
Discussed using 
NRT to quit with 
doctor 
3-month 
follow-up 
Crude β (95% CI) -0.09 (-3.57 – 3.39) 10.36 (7.92 – 12.81) 1.63 (-0.74 – 4.00) 2.78 (-0.57 – 6.13) 
Adjusted* β (95% 
CI) 
0.27 (-1.69 – 2.24) 8.58 (6.16 – 11.00) 1.67 (-0.84 – 4.18) 2.59 (-0.02 – 5.20) 
7-month 
follow-up 
Crude β (95% CI) -0.76 (-3.48 – 1.95) 11.04 (7.75 – 14.33) 5.06 (1.28 – 8.84) 8.29 (5.22 – 11.36) 
Adjusted* β (95% 
CI) 
-0.72 (-3.51 – 2.07) 9.36 (6.04 – 12.68) 4.83 (0.91 – 8.75) 7.83 (5.02 – 10.64) 
12-month 
follow-up 
Crude β (95% CI) -1.39 (-6.80 – 4.02) 11.81 (8.57 – 15.03) 7.37 (4.87 – 9.87) 9.08 (7.08 – 11.08) 
Adjusted* β (95% 
CI) 
-1.80 (-7.64 – 4.03) 9.62 (6.42 – 12.81) 6.81 (4.49 – 9.13) 8.29 (6.26 – 10.32) 
*Each analysis adjusted for group assignment, propensity score defined above, baseline total aNRT score, and 
baseline predictor variable, i.e. discussed ways to quit with doctor at baseline when assessing discussing ways to 
quit with doctor at follow-up as a predictor 
**Note: models for each predictor variable are separate analyses
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Table 12. Adjusted means and 95% confidence intervals for total aNRT scores 
by intervention at 3, 7, and 12-month follow-up 
 Intervention 
 Intervention Control 
3-month follow-up 32.97 
(31.63 – 34.34) 
32.70 
(31.35 – 34.05) 
7-month follow-up 29.40 
(27.24 – 31.56) 
30.12 
(28.49 – 31.75) 
12-month follow-up 27.37 
(23.19 – 31.55) 
29.17 
(25.12 – 33.22) 
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Table 13. Adjusted means and 95% confidence intervals for total aNRT scores 
by NRT use at 3, 7, and 12-month follow-up 
 NRT use 
 Yes No 
3-month follow-up 38.54 
(36.25 – 40.83) 
29.96 
(28.75 – 31.17) 
7-month follow-up 36.99 
(34.24 – 39.74) 
27.63 
(26.63 – 28.63) 
12-month follow-up 36.13 
(32.94 – 39.32) 
26.51 
(23.82 – 29.20) 
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Table 14. Adjusted means and 95% confidence intervals for total aNRT scores 
by discussion of ways to quit with doctor at 3, 7, and 12-month follow-up 
 Discussed ways to quit with doctor 
 Yes No 
3-month follow-up 33.51 
(32.27 – 34.75) 
31.84 
(29.86 – 33.82) 
7-month follow-up 31.99 
(29.93 – 34.05) 
27.16 
(24.87 – 29.45) 
12-month follow-up 31.69 
(28.90 – 34.48) 
24.88 
(21.93 – 27.83) 
 
  
 96 
Table 15. Adjusted means and 95% confidence intervals for total aNRT scores 
by discussion of using NRT to quit with doctor at 3, 7, and 12-month follow-up 
 Discussed using NRT to quit with doctor 
 Yes  No 
3-month follow-up 34.24 
(32.32 – 36.16) 
31.65 
(30.19 – 33.11) 
7-month follow-up 34.67 
(32.85 – 36.49) 
26.84 
(25.30 – 28.38) 
12-month follow-up 33.68 
(31.10 – 36.26) 
25.39 
(22.62 – 28.16) 
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Table 16. Association between predictors and knowledge score for 3, 7, and 12-month follow-up 
  Intervention NRT use Discussed ways to 
quit with doctor 
Discussed using 
NRT to quit with 
doctor 
3-month 
follow-up 
Crude β (95% CI) 0.01 (-0.42 – 0.45) 1.15 (0.67 – 1.64) 0.40 (0.01 – 0.79) 0.53 (0.02 – 1.04) 
Adjusted* β (95% CI) 0.14 (-0.09 – 0.37) 0.91 (0.32 – 1.50) 0.40 (0.04 – 0.77) 0.55 (0.09 – 1.01) 
7-month 
follow-up 
Crude β (95% CI) -0.32 (-0.60 – -0.03) 1.05 (0.48 – 1.62) 0.53 (-0.13 – 1.19) 0.71 (0.08 – 1.35) 
Adjusted* β (95% CI) -0.34 (-0.76 – 0.07) 0.84 (0.14 – 1.53) 0.41 (-0.22 – 1.04) 0.64 (0.06 – 1.21) 
12-month 
follow-up 
Crude β (95% CI) 0.09 (-0.58 – 0.76) 1.25 (0.81 – 1.69) 0.77 (0.32 – 1.23) 1.11 (0.67 – 1.55) 
Adjusted* β (95% CI) 0.22 (-0.56 – 1.00) 1.00 (0.53 – 1.47) 0.63 (0.20 – 1.06) 1.01 (0.57 – 1.45) 
*Each analysis adjusted for group assignment, propensity score defined above, baseline knowledge score and 
baseline predictor variable, i.e. discussed ways to quit with doctor at baseline when assessing discussing ways to 
quit with doctor at follow-up as a predictor 
**Note: models for each predictor variable are separate analyses 
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Table 17. Adjusted means and 95% confidence intervals for knowledge scores 
by intervention at 3, 7, and 12-month follow-up 
 Intervention 
 Intervention Control 
3-month follow-up 2.47 
(2.28 – 2.66) 
2.33 
(2.15 – 2.51) 
7-month follow-up 1.87 
(1.57 – 2.17) 
2.21 
(1.97 – 2.45) 
12-month follow-up 1.89 
(1.42 – 2.36) 
1.67 
(1.08 – 2.26) 
 
  
 99 
Table 18. Adjusted means and 95% confidence intervals for knowledge scores 
by NRT use at 3, 7, and 12-month follow-up 
 NRT use 
 Yes No 
3-month follow-up 2.99 
(2.54 – 3.44) 
2.08 
(1.86 – 2.30) 
7-month follow-up 2.71 
(2.10 – 3.32) 
1.87 
(1.67 – 2.07) 
12-month follow-up 2.59 
(2.10 – 3.08) 
1.59 
(1.23 – 1.95) 
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Table 19. Adjusted means and 95% confidence intervals for knowledge scores 
by discussion of ways to quit with doctor at 3, 7, and 12-month follow-up 
 Discussed ways to quit with doctor 
 Yes No 
3-month follow-up 2.55 
(2.31 – 2.79) 
2.15 
(1.90 – 2.40) 
7-month follow-up 2.26 
(1.83 – 2.69) 
1.84 
(1.57 – 2.11) 
12-month follow-up 2.09 
(1.70 – 2.48) 
1.45 
(1.03 – 1.87) 
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Table 20. Adjusted means and 95% confidence intervals for knowledge scores 
by discussion of using NRT to quit with doctor at 3, 7, and 12-month follow-up 
 Discussed using NRT to quit with doctor 
 Yes  No 
3-month follow-up 2.69 
(2.34 – 3.04) 
2.14 
(1.92 – 2.36) 
7-month follow-up 2.47 
(1.98 – 2.96) 
1.83 
(1.65 – 2.01) 
12-month follow-up 2.43 
(2.06 – 2.80) 
1.42 
(1.02 – 1.82) 
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Table 21. Association between predictors and attitude score for 3, 7, and 12-month follow-up 
  Intervention NRT use 
Discussed ways to 
quit with doctor 
Discussed using 
NRT to quit with 
doctor 
3-month 
follow-up 
Crude β (95% CI) -0.32 (-2.16 – 1.53) 4.59 (3.40 – 5.78) 0.57 (-0.65 – 1.78) 1.31 (-0.47 – 3.08) 
Adjusted* β (95% CI) -0.47 (-1.90 – 0.97) 3.81 (2.67 – 4.94) 0.08 (-1.33 – 1.49) 0.90 (-0.74 – 2.55) 
7-month 
follow-up 
Crude β (95% CI) -0.30 (-2.29 – 1.68) 5.03 (3.31 – 6.76) 1.66 (-0.23 – 3.56) 3.20 (1.67 – 4.73) 
Adjusted* β (95% CI) -0.35 (-2.00 – 1.30) 4.17 (2.26 – 6.07) 1.89 (-0.19 – 3.37) 2.92 (1.62 – 4.23) 
12-month 
follow-up 
Crude β (95% CI) -0.70 (-33.93 – 1.93) 5.54 (4.16 – 6.91) 3.62 (2.33 – 4.92) 4.16 (3.11 – 5.21) 
Adjusted* β (95% CI) -1.19 (-3.83 – 1.44) 4.79 (3.36 – 6.21) 3.53 (2.26 – 4.80) 3.92 (2.81 – 5.02) 
*Each analysis adjusted for group assignment, propensity score defined above, baseline attitude score and 
baseline predictor variable, i.e. discussed ways to quit with doctor at baseline when assessing discussing ways to 
quit with doctor at follow-up as a predictor 
**Note: models for each predictor variable are separate analyses 
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Table 22. Adjusted means and 95% confidence intervals for attitude scores by 
intervention at 3, 7, and 12-month follow-up 
 Intervention 
 Intervention Control 
3-month follow-up 17.05 
(15.88 – 18.22) 
17.51 
(16.74 – 18.28) 
7-month follow-up 15.65 
(14.24 – 17.06) 
16.00 
(15.05 – 16.95) 
12-month follow-up 14.80 
(12.86 – 16.74 
15.99 
(14.21 – 17.77) 
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Table 23. Adjusted means and 95% confidence intervals for attitude scores by 
NRT use at 3, 7, and 12-month follow-up 
 NRT use 
 Yes No 
3-month follow-up 19.84 
(18.53 – 21.15) 
16.03 
(15.25 – 16.81) 
7-month follow-up 18.99 
(17.33 – 20.65) 
14.82 
(14.05 – 15.59) 
12-month follow-up 19.31 
(17.92 – 20.70) 
14.53 
(13.26 – 15.80) 
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Table 24. Adjusted means and 95% confidence intervals for attitude scores by 
discussion of ways to quit with doctor at 3, 7, and 12-month follow-up 
 Discussed ways to quit with doctor 
 Yes No 
3-month follow-up 17.34 
(16.51 – 18.17) 
17.26 
(16.12 – 18.40) 
7-month follow-up 16.53 
(15.49 – 17.57) 
14.94 
(13.67 – 16.21) 
12-month follow-up 17.18 
(15.93 – 18.43) 
13.65 
(12.25 – 15.05) 
 
  
 106 
Table 25. Adjusted means and 95% confidence intervals for attitude scores by 
discussion of using NRT to quit with doctor at 3, 7, and 12-month follow-up 
 Discussed using NRT to quit with doctor 
 Yes  No 
3-month follow-up 17.80 
(16.58 – 19.02) 
16.90 
(15.89 – 17.91) 
7-month follow-up 17.66 
(16.60 – 18.72) 
14.74 
(13.84 – 15.64) 
12-month follow-up 17.96 
(16.58 – 19.34) 
14.04 
(12.79 – 15.29) 
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Table 26. Effect of the intervention across the study period on total aNRT scores 
Effect F-value P-value 
Intervention 0.21 0.6463 
Time 8.87 0.0002 
Intervention*Time 1.55 0.2126 
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Table 27. Mean aNRT scores by intervention status across the study period 
aNRT score Baseline* 3-months 7-months 12-months 
Intervention 29.78 
(22.70 – 36.85) 
31.63 
(29.02 – 34.24) 
29.72 
(27.16 – 32.28) 
29.24 
(26.73 – 31.75) 
Control 31.31 
(24.40 – 38.22) 
33.52 
(31.13 – 35.91) 
31.02 
(28.64 – 33.40) 
28.06 
(25.66 – 30.46) 
*Baseline scores not modeled 
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Table 28. Effect of the intervention across the study period on knowledge scores 
Effect F-value P-value 
Intervention 0.06 0.8024 
Time 6.41 0.0017 
Intervention*Time 2.88 0.0570 
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Table 29. Mean knowledge scores by intervention status across the study period 
Knowledge 
score 
Baseline 3-months 7-months 12-months 
Intervention 1.67 
(-1.09 – 4.43) 
2.28 
(1.89 – 2.67) 
1.91 
(1.53 – 2.29) 
1.95 
(1.57 – 2.33) 
Control 1.99 
(-0.66 – 4.64) 
2.36 
(2.00 – 2.72) 
2.29 
(1.94 – 2.64) 
1.65 
(1.29 – 2.01) 
*Baseline scores not modeled 
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Table 30. Effect of the intervention across the study period on attitude scores 
Effect F-value P-value 
Intervention 0.38 0.5395 
Time 7.00 0.0010 
Intervention*Time 1.34 0.2620 
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Table 31. Mean attitude scores by intervention status across the study period 
Attitude score Baseline 3-months 7-months 12-months 
Intervention 16.86 
(12.00 – 21.73) 
16.64 
(15.41 – 17.87) 
15.80 
(14.60 – 17.00) 
15.69 
(14.52 – 16.86) 
Control 17.15 
(12.31 – 21.99) 
17.89 
(16.78 – 19.00) 
16.06 
(14.95 – 17.17) 
15.37 
(14.25 – 16.49) 
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Table 32. Multiple imputation results compared to complete case analysis for the 
effect of the intervention on all aNRT outcomes at each time point 
  Complete Case 
β (95% CI) 
Multiple Imputation 
β (95% CI) 
3-month Total aNRT 0.27 
(-1.69 – 2.24) 
0.03 
(-1.48 – 1.54) 
Knowledge 0.14 
(-0.09 – 0.37) 
-0.11 
(-0.36 – 0.14) 
Attitudes -0.47 
(-1.90 – 0.97) 
0.36 
(-0.76 – 1.48) 
7-month Total aNRT -0.72 
(-3.51 – 2.07) 
-0.83 
(-3.59 – 1.92) 
Knowledge -0.34 
(-0.76 – 0.07) 
0.13 
(-0.28 – 0.53) 
Attitudes -0.35 
(-2.00 – 1.30) 
-0.28 
(-1.80 – 1.24) 
12-month Total aNRT -1.80 
(-7.64 – 4.03) 
0.50 
(-4.89 – 5.89) 
Knowledge 0.22 
(-0.56 – 1.00) 
-0.35 
(-1.11 – 0.42) 
Attitudes -1.19 
(-3.83 – 1.44) 
0.42 
(-1.85 – 2.68) 
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Figure 5. Distribution of propensity scores for intervention and control groups 
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Figure 6. DAG illustrating how previous unmeasured attitudes, aNRT(0), may affect the association between 
measured NRT use and aNRT(1); unmeasured attitudes may also be influenced by the intervention or via unknown 
variables (U) such as anecdotal experience from a friend
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EFFECT OF DEPRESSION ON SMOKING CESSATION 
 
BACKGROUND 
 
Depression is marked by depressed mood or a loss of interest in daily 
activities and may impair social, occupational, and educational function123.  
Depression and nicotine dependence are common co-occurring psychiatric 
disorders; over 50% of smokers seeking to enroll in cessation programs report at 
least one lifetime episode of major depressive disorder124–126.  Depression has 
been shown to be associated with poor smoking-related outcomes; depressed 
smokers are less likely to set a quit date, more likely to engage in heavy 
smoking, and less likely to achieve both short and long-term abstinence from 
cigarettes127–129. However, other studies130,131 show no difference in smoking 
abstinence rates between depressed and non-depressed individuals.  Given that 
cigarette smoking is the leading cause of morbidity and mortality in the United 
States (U.S.) and depression accounts for more morbidity and mortality than any 
other psychiatric diagnosis, it is important to better understand the effect of 
depression on cessation to address the burden of both diseases132–134.   
The incidence of depression is higher among those of lower 
socioeconomic status (SES) than those of higher SES28.  It is estimated that 
about 17% of those living below the poverty line in the U.S. are depressed 
compared to 4–10% for those above the poverty line135.  In a pilot study136 to 
assess the prevalence of depressive symptoms in older adult public housing 
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residents, 31% of participants screened positive for depression based on the 8-
item CES-D.  Given the higher prevalence of depression among public housing 
residents combined with the lower rates of cessation in low SES communities, it 
is relevant to examine the effect of depression on cessation in this population.  
While depression rates may be higher among public housing residents, 
levels of social support may also be greater—compared with persons of 
comparably lower SES living in the general community—due to the close 
geographical proximity of one’s social network29,137.  Among a close-knit 
community in Baltimore public housing, residents reported greater community 
cohesion such as working together to eradicate rats or supporting a family after 
the death of a loved one138.  Given the potential for greater social networks in 
public housing, it is of interest to explore the buffering effects of social support on 
the association between depression and smoking cessation.   
The positive effect of social support on health and mortality is well 
documented in a variety of populations139–141.  One psychology theory posits the 
hypothetical stress-buffering effect of social support; that is, social support can 
reduce the adverse effects of general life stressors on health16,142.  Social 
support is also known to be associated specifically with increased probability of 
quitting smoking15,52,61 , particularly among low-income and racially/ethnically 
diverse populations14,35. 
The aim of this study was to assess the effect of depression on smoking 
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cessation and determine if social support buffers the putative negative effects of 
depression.  We hypothesized that smokers with depression will have lower odds 
of biochemically-verified 7-day and 30-day PPA at 3-month follow-up, compared 
to smokers who are not depressed.  We also hypothesize social support will act 
as a moderator of the association between depression and cessation.  Increased 
levels of social support among depressed smokers will increase the odds of 
cessation compared to depressed smokers with lower social support. 
METHODS 
Design  
The design of this study was a prospective cohort using participants from 
the KIG study.  Although the parent study was a group-randomized control trial, 
depression was the main predictor of interest for this study and was not 
randomized.  Therefore, the design is considered to be a prospective cohort.   
Participants 
The analytic sample was composed of participants from the KIG study 
randomized at baseline and who completed a 3-month follow-up (n=240).  
Multiple imputation was used to account for loss to follow-up at 3-months from 
the enrolled sample at baseline (n=331). 
Exposure Measures 
Depression was the predictor of interest and was defined as follows: 
(1) CES-D-10 status at baseline using a cutoff point of 10 which has been 
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validated in multiple populations55,143–146.  The Center for Epidemiologic Studies 
Short Depression Scale (CES-D-10) is a psychometric survey developed to 
detect clinical depression.  Questions include mood experiences in the past 
week, for example “I felt happy”.  Response items were 0 days, 1–2 days, 3–4 
days, and 5–7 days.  
(2) Participant self-report of lifetime physician-diagnosed depression. 
Moderator Measure 
 
Social support was the moderator of interest and was assessed using a 
subgroup of questions from the Interpersonal Support Evaluation List (ISEL)60.  
The ISEL measures individuals’ perceptions of the availability of four types of 
support: appraisal (someone to talk to about one’s problems); belonging (people 
with whom one can do things); tangible (material aid); and self-esteem (praise 
from others or of positive social comparisons).  Individual items were scored 0 to 
3 (0= Definitely false, 3= Definitely true, range 0–24) with greater scores 
indicating greater levels of social support.  In order to assess moderation, total 
scores were dichotomized.  Due to the negative skewness of the distribution the 
scores were categorized as High, the upper quartile of the study distribution 
versus Low, the bottom three quartiles of the distribution. 
Outcome Measures 
 
The outcomes of interest were 7-day and 30-day point prevalent 
abstinence (PPA) at 3-month follow-up.  7-Day PPA was biochemically verified at 
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each follow-up whenever a participant reported smoking abstinence in the past 7 
days, using an exhaled carbon monoxide (CO) monitor test with a cutoff of ≤8 
parts per million (PPM)19. Those who self-reported abstinence but had high CO 
were re-coded as smokers.   
Covariates 
 
Demographic covariates assessed were age (18–39, 40+), sex (Female, 
Male), and race/ethnicity (White, Black, Hispanic).  Study characteristics 
including group assignment were included to control for the effects of the 
intervention.  Enrollment time defined as 3/31/2012 or earlier, 4/1/2012–
9/30/2012, 10/1/2012 or later, was included to control for the effect of the 
smoking ban that was implemented in all Boston public housing units in October 
2012.  Health status was self-report and dichotomized into excellent/very good 
versus good/fair/poor.  Smoking characteristics were nicotine dependence based 
on the Fagerstrom Test for Nicotine Dependence54 (FTND) score (≤4, 5+), and 
self-reported ever use of NRT including patches, gum, lozenges, inhaler, or nasal 
spray.   Motivation to quit was assessed by the “Readiness to Quit Ladder”56, a 
10-point ordinal measure of motivation with respect to readiness to quit smoking.  
Responses ranged from “1-I have no interest in quitting” to “10-I have quit 
smoking”.   
Perceived stress was assessed using the abbreviated 10-item version of 
the Perceived Stress Scale59 which measures how often an individual has 
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experienced stressful feelings in the past month, particularly feelings of 
unpredictability, lack of control, and being overwhelmed.  Responses ranged 
from “Never” to “Very Often” and the total scale ranged from 0–17 with higher 
scores indicating greater perceived stress.  Total stress scores were assessed as 
a continuous covariate.  Hassles was assessed using a shortened version of the 
Abbreviated Hassles Index147 which assesses a range of life hassles, such as 
being out of work for a month or longer, not having enough money for basic life 
necessities, or having a violent argument with a friend or relative.  The scale 
measures the number of stressful conditions an individual or someone close to 
the individual has experienced in the past 3 months with scores ranging from 0–
9. Total hassles scores were assessed as a continuous covariate. 
Model Building 
 
 Directed acyclic graphs (DAGs) of the relationship between depression 
and 3-month smoking abstinence were created using theoretical knowledge and 
the literature.  Crude distributions of potential baseline covariates by CES-D-10 
depression status were examined to determine variables to include in the 
propensity score model for covariate control.  Since propensity scores allow for 
more efficient control of a larger number of potential covariates than the number 
of outcomes would generally allow, a propensity score model with all potential 
covariates was utilized62.  The covariates chosen to predict depression status 
were perceived stress, previous NRT use, enrollment time, nicotine dependence, 
health status, race, group assignment, age, sex, hassles, and motivation to quit.  
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These variables were based on both the literature and empirical exploration of 
the data.  The propensity score distributions were compared between depressed 
and not depressed groups to ensure sufficient overlap and the propensity score 
values were included as an individual covariate in the final outcome models 
(Figure 7). 
Statistical Analysis 
Cessation Outcomes 
        Generalized linear models (GLM) were used to predict 7-day and 30-day 
PPA outcomes at 3-months from depression at baseline.  Models used a logit link 
and a binomial distribution to estimate odds ratios for the effect of depression on 
cessation.  For each model, adjustment was made for propensity scores.  Models 
also accounted for within-site correlation using a compound symmetrical 
structure. 
Social Support Moderation 
 
To examine the potential moderating role of social support, social support 
was dichotomized at the upper quartile cutoff to designate those of low and high 
social support.  Stratified analyses were conducted using the same cessation 
outcomes models to determine the effect of depression on cessation separately 
for those of low and high social support.  Measures of interaction were calculated 
on the additive scale using the relative excess risk due to interaction (RERI) and 
the multiplicative scale using an interaction term to calculate the ratio of odds 
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ratios (ROR). 
The potential moderating role of social support was also examined by 
comparing the joint categories of depression and social support.  A composite 
variable was created with four categories: high social support and no depression, 
high social support and depression, low social support and no depression, and 
low social support and depression.  Smoking cessation (7-day PPA and 30-day 
PPA) rates were compared using low social support and depression as the 
reference group.  This category was chosen to highlight the hypothesized 
buffering effect of social support on the relationship between depression and 
smoking cessation.  Depression was classified using the CES-D-10 scale and 
physician diagnosis. 
Sensitivity Analysis 
According to the CES-D-10, 37% of the KIG population is considered 
depressed, a rate far greater than the general population (7%) or even low-
income populations (17%)146,148. While the rate of physician-diagnosed 
depression in this sample is high (25%) compared to the general population, it is 
unlikely that the CES-D-10 is a more sensitive test compared to self-reported 
physician diagnosis.  On the contrary, it is likely that the CES-D-10 measure is 
less specific which would increase false positives.  It could also be that the cutoff 
score for the CES-D-10 is not relevant in this population based on the potential 
for non-differential misclassification due to the nature of the survey questions.  
For example, questions such as “I felt hopeful about the future” may indicate 
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circumstance for socioeconomically disadvantaged respondents versus clinical 
depression.   
Due to the higher than expected rate of depression in the KIG population, 
a sensitivity analysis was conducted to explore how results would change under 
varying scenarios of non-differential misclassification of depression.  Cutoff 
scores of CES-D-10 were varied from 10 to 15, which was based on the study 
distribution of depression scores at baseline where a cutoff score of 10 yielded 
37% depressed and a cutoff score of 16 yielded 16% depressed.  The same 
multivariate model for cessation was used to determine the effect of depression 
classified by the range of cutoff values on 7-day and 30-day PPA at 3-months.   
Based on the assumption that stronger associations would indicate less non-
differential misclassification, these results were compared to the original 
analyses to determine if a higher cutoff of CES-D-10 influenced the estimate of 
effect and consequently, whether or not there was some level of non-differential 
misclassification.  
Multiple Imputation 
 
To account for potential selection bias due to loss to follow-up, multiple 
imputation procedures were used to impute missing cessation outcome 
information for the main outcomes analysis, stratified moderation analysis, and 
sensitivity analysis.  Using Markov Chain Monte Carlo (MCMC) simulation, 
biochemically-verified past 7-day PPA and 30-day PPA were predicted from 
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baseline group assignment, health status, enrollment time, NRT use in the past 
12 months, and nicotine dependence, which were shown to predict missingness 
in this sample.  A total of n=10 imputed datasets were created and analyzed 
using the PROC MI procedure in SAS v9.4.  
RESULTS 
Demographic and Smoking Characteristics 
Among the total sample at baseline (Table 33), participants were mostly 
female (72%) and greater than age 40 (68%).  The distribution of race/ethnicity 
was 56% Black, 25% Hispanic, and 19% White/Other.  While 48% had a high 
school diploma or equivalent, 29% had less than a high school education.  Fifty-
nine percent reported they were in Good, Very Good or Excellent health.  A 
majority (57%) of participants smoked 10 or less cigarettes per day; 63% of the 
participants were classified as having low to moderate dependence on nicotine 
based on the Fagerstrom Test for Nicotine Dependence.  About half (47%) of 
participants used nicotine replacement therapy, including patches, gum, 
lozenges, inhaler, or nasal spray in the past 12 months.  A majority (78%) 
reported they had already taken actions to quit smoking and thus had high 
motivation to quit.  Among the total sample, 38% scored in the top half of the 
distribution for perceived stress.  Less than 10% reported 7–9 life hassles out of 
a possible 9 total. 
Compared to participants who were not depressed, those with CES-D-10 
classified depression were more likely to be female (83% vs. 65%), Hispanic 
 126 
(33% vs. 20%), have less than a high school education (35% vs. 25%), report fair 
or poor health (59% vs. 30%), use NRT in the past 12 months (56% vs. 41%), 
and to have been in the intervention group (58% vs. 43%).  Depressed 
participants were more likely to have higher levels of stress (70% vs. 17%), and 
also more likely to report a higher number of life hassles (13% vs. 8%).   
Effect of Depression on Cessation 
 
Among those with baseline depression classified by the CES-D 10, 15.8% 
were abstinent from cigarettes for the past 7 days and 13.7% were abstinent for 
the past 30 days at 3-month follow-up.  Among those without CES-D-10 
classified depression, 9.7% were abstinent from cigarettes for the past 7 days 
and 7.6% were abstinent for the past 30 days.  For those who self-report a 
physician diagnosis of depression, 11.4% were abstinent for both the past 7 days 
and 30 days at 3-month follow-up.  Among those who did not self-report a 
physician diagnosis of depression, 12.4% were abstinent from cigarettes for the 
past 7 days and 9.4% were abstinent for the past 30 days (Table 34). 
Participants classified as depressed according to the CES-D-10 at 
baseline were more than twice as likely to have quit smoking for the past 7 days 
compared to participants who were not depressed (OR=2.33, 95% CI: 0.86 – 
6.32) after controlling for propensity score (Table 35).  In contrast, those who 
self-reported a physician diagnosis of depression at baseline were neither more 
nor less likely to report abstinence than those without a diagnosis (OR=0.91, 
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95% CI: 0.39 – 2.10).  Similar results were seen for the effect of depression on 
30-day abstinence (Table 36).  Participants classified as depressed using the 
CES-D-10 were more than twice as likely to have been abstinent for the past 30 
days compared to those who were not depressed (OR=2.13, 95% CI: 0.81 – 
5.61) after controlling for propensity score.  Those who self-reported a physician 
diagnosis of depression at baseline were neither more nor less likely to report 
abstinence over the past 30 days than those who did not report a physician 
diagnosis (OR=1.14, 95% CI: 0.42 – 3.10).  Multiple imputation results for both 7-
day and 30-day PPA outcomes were virtually identical to the complete case 
analysis (Table 35 and Table 36).   
Moderating Role of Social Support 
Among those with high social support, those with CES-D-10 classified 
depression were more than twice as likely to have quit smoking for the past 7 
days compared to those who were not depressed (OR=2.69, 95% CI: 0.80 – 
9.12) (Table 37).  Among those with low social support, depressed smokers were 
also more than twice as likely to have quit smoking for the past 7 days compared 
to non-depressed smokers (OR=2.41, 95% CI: 0.56 – 10.45).  Measures of 
interaction confirm the lack of moderation by social support where the relative 
excess risk due to interaction (RERI) was -0.49 (-3.59 – 2.61) and the ratio of 
odds ratios (ROR) was 0.73 (0.14 – 3.70) (Table 38). 
For those with high social support, participants with CES-D-10 classified 
depression were about 50% more likely to report abstinence over the past 30 
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days compared to those who were not depressed (OR=1.57, 95% CI: 0.47 – 
5.20) (Table 39).  Among those with low social support, depressed smokers were 
almost three times as likely to report abstinence over the past 30 days compared 
to non-depressed smokers (OR=2.80, 95% CI: 0.59 – 13.36).  Measures of 
interaction were -0.82 (-4.11 – 2.47) for the RERI and 0.60 (0.11 – 3.26) for the 
ROR (Table 40).  Both indicate social support did not modify the effect of 
depression on smoking cessation. 
Multiple imputation results for the effect of CES-D-10 classified depression 
on 7-day and 30-day PPA within each social support group were similar to the 
complete case analysis.  In sum, these results suggest social support did not 
play a moderating role in the effect of CES-D-10 classified depression on 
smoking cessation (Table 37 and Table 39).   
Using self-reported physician diagnosis to classify depression, depressed 
smokers in the high social support group were about twice as likely to have quit 
smoking for the past 7 days compared to non-depressed smokers (OR=2.07, 
95% CI: 0.65 – 6.59) (Table 41).  In contrast, physician-diagnosed depressed 
smokers with low social support were about half as likely to quit smoking for the 
past 7 days compared to non-depressed smokers (OR=0.44, 95% CI: 0.09 – 
2.20).  Measures of interaction were 0.87 (-0.45 – 2.20) for the RERI which gives 
some evidence for moderation by social support on the additive scale and 2.97 
(0.38 – 23.10) for the ROR which suggests the effect of depression among 
smokers with low social support is greater than for those with high social support 
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on the multiplicative scale (Table 42). 
 In the high social support group, those with self-reported physician-
diagnosed depression were almost three times as likely to quit smoking for the 
past 30 days compared to non-depressed smokers (OR=2.93, 95% CI: 0.57 – 
15.10) while depressed smokers in the low social support group were about half 
as likely to quit for the past 30 days compared to non-depressed smokers 
(OR=0.54, 95% CI: 0.11 – 2.56) (Table 43).  Measures of interaction on both the 
additive scale (RERI = 1.05 [-0.44 – 2.53]) and the multiplicative scale (ROR = 
3.51 [0.40 – 30.91]) suggest the effect of depression on cessation is greater 
among those with low social support than those with high social support (Table 
44).  
While differences in the social support-stratified point estimates suggests 
a moderating role of social support for the effect of physician-diagnosed 
depression on smoking cessation, we should be cautious of this interpretation 
due to the wide and overlapping confidence intervals.  There were a limited 
number of individuals with physician-diagnosed depression who reported 7-day 
PPA (n=8) and thus when stratified an even smaller number who reported 
abstinence in the high (n=5) and low (n=3) social support groups.  This led to 
insufficient power to detect differences between the high and low social support 
groups and limits the evidence for moderation by social support of the physician-
diagnosed depression effect on smoking cessation.    
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 Multiple imputation results were directionally similar, i.e. physician-
diagnosed depressed smokers in the high social support group were more likely 
to quit smoking than non-depressed smokers, and physician-diagnosed 
depressed smokers in the low social support group were less likely to quit 
smoking than non-depressed smokers.  The magnitude of effects were closer to 
the null than the complete case analyses and again, cautious interpretations are 
necessary due to the limited precision of the estimates (Table 41 and Table 43).  
  
 The distribution of depression and social support was re-classified into 
four categories to examine the joint effects on smoking cessation.  While we 
hypothesized buffering effects of social support on cessation, those with CES-D-
10 classified depression were more likely to quit smoking than those without 
depression, regardless of whether they had low or high social support.  Results 
were similar for both 7-day PPA (Table 45) and 30-day PPA (Table 46) 
outcomes.   
 In contrast, when examining the joint effect of physician diagnosed 
depression and social support, among smokers with low social support, 
depressed smokers were less likely to report abstinence than non-depressed 
smokers.  Among smokers with high social support, depressed smokers were 
more likely to report abstinence than non-depressed smokers.  Again, results 
were consistent for both 7-day PPA (Table 47) and 30-day PPA (Table 48) 
outcomes. Note, these results should be interpreted cautiously due to the lack of 
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precision in the confidence intervals due to the limited number of cases of 
physician-diagnosed depression. 
Sensitivity Analysis 
Cutoff scores for depression classification using CES-D were varied from 
10 to 15.  New depression classifications were then used to determine the effect 
of depression on 7-day and 30-day PPA (Table 49 and Table 50).  Results 
showed that depressed smokers were more likely to quit than non-depressed 
smokers using CES-D values of 10 to 13 and a consistent trend towards the null 
was evident as the cutoff value was increased.  Using a CES-D value of 14 to 
classify depression, the estimate of effect was reversed and depressed smokers 
were less likely to quit smoking.  Similar results were found using a CES-D value 
of 15 for depression classification.  While a CES-D cutoff value of 14 or 15 was 
consistently associated with lower odds of cessation for depressed smokers than 
non-depressed smokers, confidence intervals were wide and overlapping due to 
the smaller number of depressed smokers.   
DISCUSSION 
 
Findings on the Effect of Depression on Smoking Cessation 
We found depression classified by the CES-D-10 at baseline was 
associated with increased smoking cessation rates at 3-month follow-up.  There 
was a consistently positive effect of CES-D-10 depression on smoking cessation 
in our public housing sample where depressed smokers were more likely to quit 
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smoking than those who were not depressed.  While this could be due to 
differential participation in the intervention group such that depressed smokers 
were more likely to follow-up at 3-months than smokers who were not depressed, 
we found a similar percentage of depressed smokers (65.3%) as non-depressed 
smokers (67.4%) completed the 3-month follow-up.  It could also be that the 
CES-D-10 itself was not an appropriate assessment of depression for public 
housing residents since the shortened scale has not been validated in a 
socioeconomically disadvantaged population (although the full version has been 
validated among low-income women149).  However, the results of the sensitivity 
analysis, which will be explored in further detail below, suggest at least the 
consistency of the CES-D in identifying a positive relationship between 
depression and smoking cessation.   
In the context of the KIG intervention, it could be that the strength of the 
intervention effect overwhelmed the potential negative effect of depression on 
cessation.  While we controlled for the effect of group assignment, there may 
have been residual pathways through which the intervention influenced smoking 
cessation that we did not control.  However, post-hoc analyses showed that even 
among the control group, CES-D-10 depressed smokers were still more likely to 
quit than non-depressed smokers for the past 7 days (OR=1.68, 95% CI: 0.40 – 
7.03).  Thus, it would seem our results suggest depression does not harm 
smoking cessation efforts, and in fact participants with depression have better 
cessation outcomes than those without depression.  This finding is in contrast to 
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the large body of literature which suggests depression and other serious mental 
illness can hinder smoking cessation efforts127,150–156.  Even among low-income 
and racially/ethnically diverse populations, there is evidence that depression 
lowers the probability of quitting smoking157,158.   
There is no literature that we know of to support the positive effect of 
baseline depression on smoking cessation.  This could be due to publication bias 
where studies that may have found a similar positive effect were not reported due 
to the extensive and contrasting current literature.  Our study assessed 
depression at baseline, but Catley, et al.159 showed increases in depressive 
symptoms over time were predictive of negative smoking cessation outcomes.  It 
could also be that the effect of depression on smoking cessation is truly positive 
in this population of smokers living in public housing.  If so, this would be 
encouraging for smokers who are depressed and want to enroll in cessation 
interventions.  Particularly for socioeconomically disadvantaged smokers who 
already face incredible barriers to quitting smoking, this study supports the idea 
that psychosocial functioning should not hinder cessation efforts.   
Smokers with self-report physician diagnosed depression were not more 
or less likely to quit smoking than smokers without depression.  However, these 
results were less reliable due to the limited number of cases and the potential for 
recall bias of self-report diagnosis.  Participants were also asked if they had ever 
been diagnosed with depression and so the timing and currency of symptoms 
may not have been relevant to when cessation was assessed.  Nevertheless, 
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more recent literature supports our findings of no association between physician-
diagnosed depression and smoking cessation.  A meta-analysis160 of 31 studies 
on co-morbid tobacco use disorder and depression found depression did not 
have a negative impact on smoking cessation outcomes.   Our study measured 
depression at baseline and other studies have also shown that baseline 
depressive symptoms or diagnoses are unrelated to smoking cessation 
outcomes91,159,161.  Furthermore, Catley, et al.162 found depressive symptoms 
were not associated with failure to quit among African Americans in a smoking 
cessation intervention trial.  Castro, et al.26 found no relationship between 
depression and cessation in a cohort of Latino smokers.  These studies support 
our findings that depression does not negatively impact smoking cessation 
among ethnically/racially diverse smokers.     
Findings on the Moderating Role of Social Support 
 Independent of the overall effect of depression on smoking cessation, we 
hypothesized social support would act as a moderator of the relationship 
between depression and cessation.  However, we found no evidence of 
moderation by social support on the relationship between CES-D-10 depression 
and cessation outcomes.  Interestingly, among all sub-groups of social support, 
depressed smokers were more likely to quit than non-depressed smokers.  All 
measures of interaction also supported the lack of a moderating effect by social 
support.   
 In contrast, among participants with high social support, there was a 
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consistent positive effect of physician-diagnosed depression on cessation such 
that those with depression were more likely to quit smoking than those without 
depression.  Among participants with low social support, the opposite effect was 
seen where those with physician-diagnosed depression were about half as likely 
to quit smoking as those without depression.  While these results suggest 
depression had a greater effect on cessation among those in the low social 
support group than those in the high social support group, these conclusions are 
tenuous given the substantial imprecision of the effect estimates.  In this sample, 
there were a limited number of physician-diagnosed depression cases in each 
sub-group of social support.  Thus, it is difficult to make a definitive conclusion on 
whether social support moderates the effect of physician-diagnosed depression 
on cessation. 
 The literature on the role of social support in smoking cessation is mixed.  
Some studies show increased social support, mostly through spouses or 
partners, is associated with cessation35,52,61,163.  However, other studies 
demonstrate a lack of effectiveness of social support in increasing quit rates, 
even among interventions which targeted increasing social support164,165.  There 
is only one study we are aware of that has examined social support as a 
moderator of the relationship between depression and smoking cessation.  
Brothers and Borrelli15 found social support buffered the negative effects of 
depression in a cohort of Latino smokers.  Among smokers with high levels of 
social support, quit rates were similar among depressed and non-depressed 
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smokers.  However, among smokers with low levels of social support, quit rates 
were higher for non-depressed smokers than for depressed smokers.  Our CES-
D depression results, which are more reliable than the physician-diagnosed 
depression results, contradict these findings and suggest social support does not 
modify the effect of depression on cessation.   
 There are several potential explanations for the failure to see a 
moderating effect of social support.  First, 53% of participants at baseline 
reported high levels of social support.  It is possible in our study of public housing 
residents that these already high levels of social support led to a ceiling on 
potential buffering effects.  This is plausible given that studies show the dynamics 
of public housing communities encourage greater social support through the 
close geographic proximity to people of similar backgrounds29,137,138.  Second, it 
may be that among this population social support buffers the effects of 
depression on smoking cessation in the long-term, but not the short-term as our 
study only assessed the effect on 3-month abstinence.  This contrasts with 
Brothers and Borrelli15 who found buffering effects of social support on cessation 
outcomes at 3-months.  Finally, there was limited power in our study to detect a 
moderating effect of social support, especially for physician-diagnosed 
depression.  A recent study suggests social support interventions may only 
increase smoking cessation rates up to 5%166.  A combination of the limited 
capacity of social support to increase smoking cessation and the reduced power 
of our study to detect clinically significant differences may have contributed to our 
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failure to find a moderating effect of social support.    
Given the secondary nature of our study and the limited power to detect 
interaction, it is clear that further studies need to be done to determine the role of 
social support in potentially buffering the negative effects of depression on 
cessation in socioeconomically disadvantaged populations.  Furthermore, it is 
noteworthy that our conclusions on social support moderation were dependent 
on the measure of depression in this study.  These results highlight the need to 
examine the validity of the CES-D-10 in a socioeconomically disadvantaged 
population such as public housing residents. 
Findings on the Sensitivity Analysis 
 To evaluate the potential for misclassification of depression according to 
the CES-D-10, we conducted a sensitivity analysis where cutoff scores for 
depression classification were varied from 10 to 15.  These values were selected 
to yield lower depression prevalence estimates, which we suspected to be more 
appropriate in this population of public housing residents.  According to Hitsman, 
et al.167, smoking cessation trials that do not require a history of depression may 
overestimate depression rates when using brief screening scales.  The effect of 
depression on 7-day and 30-day PPA at 3-months was then re-evaluated for 
each new depression classification.  Results indicated that with greater cutoff 
values of CES-D, the prevalence of depression decreased which was expected 
with the higher standard of depression.  The effect of depression on cessation 
was closer to the null until a cutoff score of 14 where the effect was beyond the 
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null and this was maintained at a cutoff score of 15.  Results were consistent for 
both 7-day and 30-day PPA outcomes.   
 These findings were not what we anticipated.  We assumed depression 
classification did not differ by cessation status and was statistically independent 
of true depression status, which would result in misclassification error that was 
independent and non-differential.  Thus, if the true prevalence of depression in 
this sample were overestimated by CES-D-10, we expected the measurement of 
CES-D-10 to have the greatest amount of misclassification error and the effect of 
CES-D-10 depression on smoking to have the greatest amount of bias towards 
the null.  Increasing the cutoff score of CES-D and reducing the prevalence of 
classified depression should then have yielded estimates that were further from 
the null if the bias was corrected.  However, we saw entirely contrary results.  As 
the stringency of depression classification increased, the prevalence of 
depression was reduced, but the effect of depression on cessation was closer to 
the null. 
There are a few reasons that could explain these unexpected sensitivity 
analysis results.  It could be that there is minimal misclassification error at the 
cutoff score of CES-D-10 and that the shortened version of the CES-D is an 
appropriate measure of depression in this population.  While the shortened scale 
has not been validated in low-income or ethnically/racially diverse populations 
except for older Chinese adults145, it has been validated in multiple other 
vulnerable populations, including the elderly, HIV-positive, and psychiatric 
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inpatients55,143,144,168.   The expected direction of bias with independent, non-
differential misclassification error is towards the null, but in cases where 
differential or random error is also present169,170, polytomous exposure categories 
are collapsed171, or continuous measures are categorized172, the expected 
direction of bias may not be towards the null.  However, we do not suspect any of 
these circumstances to apply to depression classification by the CES-D scale. 
Another possibility in rare cases for independent, non-differential 
misclassification error to result in bias that moves the effect estimate away from 
the null occurs when sensitivity and specificity of the measurement tool are very 
low173.  Using physician-diagnosed depression as the gold standard, we found 
sensitivity and specificity values of CES-D measurements ranging from 10 to 15 
to be very low.  However, the sum of these sensitivity and specificity values for 
each depression classification were not less than 1, the quantitative criterion to 
produce bias away from the null.  Notably, our use of physician-diagnosed 
depression as the gold standard is problematic due to the self-report nature of 
the measure.   
While the totality of evidence suggests the use of the CES-D-10 to 
diagnose depression in this population is seemingly sufficient, there remains the 
limitation of the non-specificity of the scale.  For example, public housing 
residents may be in an unsafe environment or experience conflict escalation in 
their neighborhoods so may endorse items such as “I felt fearful” or “My sleep 
was restless”.  Public housing residents are a socioeconomically disadvantaged 
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group so their economic or social situations may have led them to endorse items 
such as “I felt everything I did was an effort” or not endorse items such as “I felt 
hopeful about the future”.  Additionally, items such as “I was happy” and “I felt 
lonely” may be due to a variety of contextual and time-varying circumstances that 
are independent of clinical depression.   
We examined the frequency of CES-D-10 responses to further explore 
whether the scale may be too general to assess clinical depression in this public 
housing sample.  At baseline, the items most likely to be endorsed by 
participants for at least 5–7 days in the past week were “My sleep was restless” 
(25.8%), “I felt everything I did was an effort” (14.6%), and “I felt depressed” 
(11.3%).  So, the two highest frequency items support our conclusion about the 
non-specific nature of the scale.  However, the third-highest item endorsed 
suggests the CES-D is sufficiently specific.   In sum, these post-hoc analyses 
lead us to the same conclusions as the sensitivity analysis, which are that the 
CES-D-10 is likely a valid tool to assess depression in a socioeconomically 
disadvantaged population.  It could be that the factor structure for the shortened 
version varies depending on the cultural context, which was found to be true for 
the full-item version 174.  In any case, our results further solidify the need for the 
CES-D-10 to be validated in low-income and racially/ethnically diverse 
populations such as among public housing residents. 
There are implications of our results that may be relevant to how future 
interventions may be designed to help socioeconomically disadvantaged 
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populations achieve smoking abstinence.  While it may be assumed that 
participants with depressed mood would not have positive outcomes in a 
smoking cessation intervention, our results indicate cessation outcomes are not 
negatively impacted by participant’s depression status.  Moreover, depressed 
participants in our study were more likely to report smoking abstinence than non-
depressed participants and thus, depressed patients should be encouraged to 
enroll in interventions that will help them achieve cessation.   While we were 
unable to find a moderating effect of social support, even among participants with 
low social support there was at least no effect of physician-diagnosed depression 
on cessation and still a positive effect of CES-D-10 depression on cessation.  
Baseline levels of social support were also high in this public housing population 
and the power of this network could be harnessed in future studies using more 
community-based intervention approaches.  Finally, it is recommended that 
smoking cessation interventions for smokers with depression include a 
psychosocial mood management component to increase abstinence rates175.  
Our results echo this sentiment, as it is likely the positive effect of depression on 
cessation was facilitated by the TTA intervention.  Although we controlled for 
group assignment, perhaps the motivational interviewing component and 
interaction with the TTA was key in helping depressed smokers achieve 
abstinence.  We recommend future cessation studies consider the use of a 
community health worker trained in motivational interviewing as an aspect of their 
interventions. 
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Strengths and Limitations 
 
There were limitations of this study due to the use of data from the Kick it 
for Good trial.  First, the KIG study was not designed to assess the effects of 
depression on cessation and so the exposure variable in this dissertation study 
was not randomized.  Thus, we did not expect a balance of individual-level 
characteristics between depressed and non-depressed groups and had to 
sufficiently control for residual confounding through the use of propensity scores.  
Second, the survey questions for KIG were previously developed for different 
aims and hypotheses, so there were limitations with respect to the measurement 
and operationalization of variables used in the current study.  For example, social 
support was measured using the Interpersonal Support Evaluation List (ISEL), an 
8-item scale intended for interpretation using the continuous sum score.  
However, since social support was an important moderator, categorization was 
required to execute the relevant analysis.  Additionally, we were limited to using a 
highest quartile cutoff for the categorization due to sample size limitations and 
the overall high levels of social support in this sample.  Also, the ISEL pertains to 
general social support; however, it would be more theoretically relevant if social 
support were gauged with respect to specific smoking and cessation behaviors.   
There were additional limitations of this study due to its design.  The 
temporality of the exposure measure was difficult to establish due to the natural 
etiology of depression.  Even among the limited number of participants who 
completed all follow-up assessments, there was a lack of consistency of 
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depression status via both CES-D-10 and self-report physician diagnosis across 
follow-up assessments.  This may have been due to recall bias or the lack of 
clear timeframe since participants were asked if they had ever been diagnosed 
with depression.  The inconsistency could also have been due to the dynamic 
nature of depression, particularly in this socioeconomically disadvantaged 
population, and thus we limited outcome assessments to the 3-month follow-up.  
However, this design aspect prevented us from examining the effect of 
depression on cessation outcomes across the study period and may have 
contributed to the unlikely results observed.  It could be that depression did not 
negatively affect cessation at 3-months due to the intensity of the current 
intervention period which lasted until 6-months post-baseline, but we do not know 
where the effect persisted at 7-month or 12-month follow-up.  We were limited by 
the available depression measures of CES-D-10 classified depression and self-
report of physician diagnosis, which were inconsistent between variables and 
also across time.  The ideal standard for exposure measurement would have 
been clinical diagnosis by a physician that was verified through medical records.   
Another limitation of the study design was the propensity score model 
used to control for confounding.  At the outset of the study, we hypothesized 
baseline levels of stress, hassles, and motivation to quit to be potential 
confounders.  Stratified analyses indicated a relative balance of hassles and 
motivation to quit between depression groups, but a stark difference in stress 
where 70% of the depressed group reported high levels of stress at baseline 
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compared with 17% of the non-depressed group.  Due to the limited number of 
cessation outcomes, the propensity score method allowed us to adjust for all our 
potential covariates more efficiently and so all theoretical confounders were 
included in the propensity score model.  However, the argument could be made 
that stress, hassles, and motivation to quit exist on a causal pathway between 
depression and smoking cessation (Figure 8).  For example, depression may 
hinder daily functioning and cause participants to report higher perceived levels 
of stress, higher numbers of perceived life hassles, and less motivation to quit 
smoking, all of which may affect their ability to achieve smoking cessation.  Thus, 
to explore the impact of including stress, hassles, and motivation to quit in the 
propensity score, we removed these variables from the model.  We found the 
distribution of propensity scores in the depressed and non-depressed groups to 
have greater overlap than the distribution with the full model, indicating the three 
variables were likely highly associated with depression although these results do 
not indicate direction.  However, when the main effects analyses were re-run for 
7-day PPA (Table 51) and 30-day PPA (Table 52) outcomes, there were minimal 
differences in the effects of both CES-D-10 depression and physician-diagnosed 
depression.  Thus, while the inclusion of stress, hassles, and motivation to quit 
may have resulted in a partial removal of the depression effect on cessation that 
was mediated by those variables, the strength of those pathways was minimal.   
Other sources of bias were likely minimal in this study.  The potential for 
selection bias was limited due to the use of the 3-month follow-up as the single 
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outcome time point.  Also, the multiple imputation results were highly similar to 
the complete case analysis for both the overall effect of depression on cessation 
and for the social support moderation analyses so selection bias due to loss to 
follow-up was also likely negligible.  Finally, the potential for misclassification of 
cessation outcomes was low due to the use of biochemically-verified abstinence.   
Future Research Directions 
 The findings presented here should be replicated in other 
socioeconomically disadvantaged populations.  We saw differing effects of 
depression based on whether it was measured by the CES-D-10 or self-report of 
physician diagnosis.  Future studies should establish a more clear exposure 
measurement by verifying depression status with medical records or physician 
diagnosis.  It would also be of interest to explore whether a change in depression 
was seen over the course of the study and if that was influenced by the TTA 
intervention.  This change in depression may have had a differing effect on 
cessation than what our results showed using baseline depression measures.  
The effect of depression on cessation should also be examined over longer 
follow-up periods.  We did not have sufficient power to detect moderation of the 
effect of depression on cessation by social support, and recommend future 
studies examine these associations.  This issue is particularly salient as overall 
levels of social support were high in our sample of public housing residents and 
thus the power of social networks could be easily harnessed in this population.  
Since the KIG study was designed as a smoking cessation intervention, our use 
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of the data to examine depression effects was limited.  Ideally, future studies 
would be designed to answer the specific questions of whether depression 
affects smoking cessation and whether social support moderates that association 
in socioeconomically disadvantaged populations.  
Conclusion 
Our study suggests that among those with depression classified by the 
CES-D-10, cessation is not impacted by their depressed mood.  Moreover, those 
with CES-D-10 classified depression were more likely to report abstinence from 
cigarettes than those without depression in this public housing sample.  In 
contrast to the CES-D-10 results, we saw no effect of physician-diagnosed 
depression on cessation although there was limited power to detect this effect.  
Our results highlight the need for sound methodology for measuring depression 
in a socioeconomically disadvantaged population.  We also did not find evidence 
for social support as a moderator of the depression effect on cessation.  
Nevertheless, it is encouraging that depression status does not seem to hinder 
smoking cessation efforts and in fact, depressed smokers do quite well in the 
context of a community-based cessation intervention.  
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Table 33. Baseline demographic, health and smoking characteristics of KIG 
sample (n=331) 
 Total Sample 
(n=331) 
n (%) 
CES-D-10 
Depressed 
(n=130) 
n (%) 
CES-D-10  
Not Depressed  
(n=201) 
n (%) 
Age 
   18–39 
   40+ 
 
106 (32.0) 
225 (68.0) 
 
37 (28.5) 
93 (71.5) 
 
69 (34.3) 
132 (65.7) 
Sex 
   Female 
   Male 
 
239 (72.2) 
92 (27.8) 
 
108 (83.1) 
22 (16.9) 
 
131 (65.2) 
70 (34.8) 
Race 
   Hispanic 
   Black 
   White/Other 
 
84 (25.4) 
183 (55.3) 
64 (19.3) 
 
43 (33.1) 
62 (47.7) 
25 (19.2) 
 
41 (20.4) 
121 (60.2) 
39 (19.4) 
Education 
   Less than high school 
   High school or equivalent 
   Some college 
   College graduate 
 
97 (29.3) 
158 (47.8) 
56 (16.9) 
20 (6.0) 
 
46 (35.4) 
51 (39.2) 
24 (18.5) 
9 (6.9) 
 
51 (25.4) 
107 (53.2) 
32 (15.9) 
11 (5.5) 
Health 
   Fair/Poor 
   Good/Very Good/Excellent 
 
136 (41.1) 
195 (58.9) 
 
76 (58.5) 
54 (41.5) 
 
60 (29.9) 
141 (70.2) 
Cigarettes per day 
   ≤10 
   11+ 
 
189 (57.1) 
142 (42.9) 
 
69 (53.1) 
61 (46.9) 
 
120 (59.7) 
81 (40.3) 
Fagerstrom Test for Nicotine 
Dependence* 
   ≤4 (low to moderate) 
   5+ (moderate to high) 
 
 
207 (62.7) 
123 (37.3) 
 
 
73 (56.6) 
56 (43.4) 
 
 
134 (66.7) 
67 (33.3) 
NRT use past 12 months 
   Yes 
   No 
 
155 (46.8) 
176 (53.2) 
 
73 (56.2) 
57 (43.9) 
 
82 (40.8) 
119 (59.2) 
Motivation to quit  
   Low (1–3) 
   Medium (4–6) 
   High (7–10) 
 
9 (2.7) 
63 (19.0) 
259 (78.3) 
 
2 (1.5) 
27 (20.8) 
101 (77.7) 
 
7 (3.5) 
36 (17.9) 
158 (78.6) 
Stress 
   High (9–17) 
   Low (0–8) 
 
126 (38.1) 
205 (61.9) 
 
91 (70.0) 
39 (30.0) 
 
35 (17.4) 
166 (82.6) 
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 Total Sample 
(n=331) 
n (%) 
CES-D-10 
Depressed 
(n=130) 
n (%) 
CES-D-10  
Not Depressed  
(n=201) 
n (%) 
Hassles 
   High (7–9) 
   Medium (4–6) 
   Low (0–3) 
 
32 (9.7) 
119 (36.0) 
180 (54.4) 
 
17 (13.1) 
52 (40.0) 
61 (46.9) 
 
15 (7.5) 
67 (33.3) 
119 (59.2) 
Social Support 
   High  
   Low 
 
176 (53.2) 
155 (46.8) 
 
45 (34.6) 
85 (65.4) 
 
131 (65.2) 
70 (34.8) 
Enrollment time 
   10/1/2012 or later 
   4/1/2012–9/30/2012 
   3/31/2012 or earlier 
 
143 (43.2) 
122 (36.9) 
66 (19.9) 
 
52 (40.0) 
56 (43.1) 
22 (16.9) 
 
91 (45.3) 
66 (32.8) 
44 (21.9) 
Intervention Group 
   Motivational Interview 
   Standard Control 
 
170 (51.4) 
161 (48.6) 
 
75 (57.7) 
55 (42.3) 
 
86 (42.8) 
115 (57.2) 
*Missing n=1 
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Table 34. 7-day and 30-day PPA by depression status 
 CES-D-10 Physician Diagnosis 
 Depression No Depression Depression No Depression 
7-day PPA % 15.8 9.7 11.4 12.4 
30-day PPA % 13.7 7.6 11.4 9.4 
  
 150 
Table 35. Effects of depression on 7-day PPA using different measurements of 
baseline depression status 
 CES-D-10 depression Physician-diagnosed 
depression 
Crude OR (95% CI) 1.76 (0.78 – 3.97) 0.92 (0.41 – 2.09) 
Adjusted OR (95% CI) 2.33 (0.86 – 6.32) 0.91 (0.39 – 2.10) 
Multiple Imputation OR 
(95% CI) 
2.39 (0.86 – 6.62) 0.88 (0.35 – 2.24) 
*Note: models for each depression predictor variable are separate analyses 
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Table 36. Effects of depression on 30-day PPA using different measurements of 
baseline depression status 
 CES-D-10 depression Physician-diagnosed 
depression 
Crude OR (95% CI) 1.91 (0.92 – 3.99) 1.23 (0.45 – 3.32) 
Adjusted OR (95% CI) 2.13 (0.81 – 5.61) 1.14 (0.42 – 3.10) 
Multiple Imputation OR 
(95% CI) 
2.20 (0.78 – 6.18) 1.06 (0.39 – 2.89) 
*Note: models for each depression predictor variable are separate analyses 
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Table 37. Effects of CES-D-10 classified depression on 7-day PPA among those 
with low and high social support 
 Complete case analysis Multiple imputation 
Overall effect OR (95% CI) 2.33 (0.86 – 6.32) 2.39 (0.86 – 6.62) 
High social support OR 
(95% CI) 
2.69 (0.80 – 9.12) 2.41 (0.67 – 8.65) 
Low social support OR 
(95% CI) 
2.41 (0.56 – 10.45) 2.79 (0.74 – 10.51) 
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Table 38. Additive scale (RERI) and multiplicative scale (ROR) measures of 
interaction for the joint effect of CES-D-10 classified depression and social 
support on 7-day PPA 
Additive Scale RERI (95% CI) Multiplicative Scale ROR (95% CI) 
-0.49 (-3.59 – 2.61) 0.73 (0.14 – 3.70) 
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Table 39. Effects of CES-D-10 classified depression on 30-day PPA among 
those with low and high social support 
 Complete case analysis Multiple imputation 
Overall effect OR (95% CI) 2.13 (0.81 – 5.61) 2.20 (0.78 – 6.18) 
High social support OR 
(95% CI) 
1.57 (0.47 – 5.20) 1.79 (0.47 – 6.79) 
Low social support OR 
(95% CI) 
2.80 (0.59 – 13.36) 3.04 (0.71 – 13.02) 
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Table 40. Additive scale (RERI) and multiplicative scale (ROR) measures of 
interaction for the joint effect of CES-D-10 classified depression and social 
support on 30-day PPA 
Additive Scale RERI (95% CI) Multiplicative Scale ROR (95% CI) 
-0.82 (-4.11 – 2.47) 0.60 (0.11 – 3.26) 
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Table 41. Effects of physician-diagnosed depression on 7-day PPA among those 
with low and high social support 
 Complete case analysis Multiple imputation 
Overall effect OR (95% CI) 0.91 (0.39 – 2.10) 0.88 (0.35 – 2.24) 
High social support OR 
(95% CI) 
2.07 (0.65 – 6.59) 1.38 (0.38 – 4.97) 
Low social support OR 
(95% CI) 
0.44 (0.09 – 2.20) 0.52 (0.10 – 2.66) 
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Table 42. Additive scale (RERI) and multiplicative scale (ROR) measures of 
interaction for the joint effect of physician diagnosed depression and social 
support on 7-day PPA 
Additive Scale RERI (95% CI) Multiplicative Scale ROR (95% CI) 
0.87 (-0.45 – 2.20) 2.97 (0.38 – 23.10) 
 
  
 158 
Table 43. Effects of physician-diagnosed depression on 30-day PPA among 
those with low and high social support 
 Complete case analysis Multiple imputation 
Overall effect OR (95% CI) 1.14 (0.42 – 3.10) 1.06 (0.39 – 2.89) 
High social support OR 
(95% CI) 
2.93 (0.57 – 15.10) 1.72 (0.43 – 6.87) 
Low social support OR 
(95% CI) 
0.54 (0.11 – 2.56) 0.62 (0.11 – 3.44) 
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Table 44. Additive scale (RERI) and multiplicative scale (ROR) measures of 
interaction for the joint effect of physician diagnosed depression and social 
support on 30-day PPA 
Additive Scale RERI (95% CI) Multiplicative Scale ROR (95% CI) 
1.05 (-0.44 – 2.53) 3.51 (0.40 – 30.91) 
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Table 45. Effects of joint distribution of CES-D-10-classified depression and 
social support on 7-day PPA 
 7-day PPA n (%) OR (95% CI) 
High social support 
and no depression 
9 (10.3) 0.40 (0.15 – 1.05) 
High social support 
and depression  
5 (14.3) 0.76 (0.25 – 2.21) 
Low social support 
and no depression 
5 (8.6) 0.34 (0.11 – 1.04) 
Low social support 
and depression 
10 (16.7) Ref 
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Table 46.Effects of joint distribution of CES-D-10-classified depression and social 
support on 30-day PPA 
 30-day PPA n (%) OR (95% CI) 
High social support 
and no depression 
7 (8.1) 0.43 (0.14 – 1.30) 
High social support 
and depression  
4 (11.4) 0.68 (0.24 – 1.91) 
Low social support 
and no depression 
4 (6.9) 0.36 (0.10 – 1.29) 
Low social support 
and depression 
9 (15.0) Ref 
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Table 47. Effects of joint distribution of physician diagnosed depression and 
social support on 7-day PPA 
 7-day PPA n (%) OR (95% CI) 
High social support 
and no depression 
9 (10.2) 1.23 (0.28 – 5.46) 
High social support 
and depression  
5 (14.7) 1.89 (0.32 – 11.09) 
Low social support 
and no depression 
12 (14.6) 1.87 (0.37 – 9.43) 
Low social support 
and depression 
3 (8.3) Ref 
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Table 48. Effects of joint distribution of physician diagnosed depression and 
social support on 30-day PPA 
 30-day PPA n (%) OR (95% CI) 
High social support 
and no depression 
6 (6.8) 0.90 (0.20 – 4.02) 
High social support 
and depression  
5 (14.7) 1.95 (0.35 – 11.00) 
Low social support 
and no depression 
10 (12.3) 1.61 (0.32 – 8.06) 
Low social support 
and depression 
3 (8.3) Ref 
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Table 49. Changes in effect of depression on 7-day PPA when using different 
cutoff values for CES-D depression 
 Classified 
Depressed 
n (%) 
Complete Case 
Analysis 
OR (95% CI) 
Multiple Imputation 
OR (95% CI) 
CES-D-10 95 (39.6) 2.33 (0.86 – 6.32) 2.39 (0.86 – 6.62) 
CES-D-11 79 (32.9) 1.51 (0.63 – 3.62) 1.83 (0.74 – 4.47) 
CES-D-12 71 (29.6) 1.15 (0.48 – 2.78) 1.32 (0.47 – 3.67) 
CES-D-13 54 (22.5) 1.17 (0.39 – 3.52) 1.19 (0.46 – 3.06) 
CES-D-14 46 (19.2) 0.56 (0.11 – 2.88) 0.78 (0.23 – 2.58) 
CES-D-15 41 (17.1) 0.69 (0.13 – 3.62) 0.94 (0.28 – 3.09) 
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Table 50. Changes in effect of depression on 30-day PPA when using different 
cutoff values for CES-D depression 
 Classified 
Depressed 
n (%) 
Complete Case 
Analysis 
OR (95% CI) 
Multiple Imputation 
OR (95% CI) 
CES-D-10 95 (39.6) 2.13 (0.81 – 5.61) 2.20 (0.78 – 6.18) 
CES-D-11 79 (32.9) 1.50 (0.52 – 4.27) 1.76 (0.62 – 4.96) 
CES-D-12 71 (29.6) 1.03 (0.37 – 2.90) 1.19 (0.38 – 3.71) 
CES-D-13 54 (22.5) 1.38 (0.44 – 4.38) 1.30 (0.47 – 3.58) 
CES-D-14 46 (19.2) 0.62 (0.11 – 3.44) 0.80 (0.24 – 2.66) 
CES-D-15 41 (17.1) 0.76 (0.13 – 4.27) 0.96 (0.28 – 3.22) 
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Table 51. Effects of depression on 7-day PPA using two propensity score models 
 CES-D-10 depression Physician-diagnosed 
depression 
Crude OR (95% CI) 1.76 (0.78 – 3.97) 0.92 (0.41 – 2.09) 
PS 1-adjusted OR* (95% CI) 2.33 (0.86 – 6.32) 0.91 (0.39 – 2.10) 
PS 2-adjusted OR** (95% CI) 2.09 (0.94 – 4.66) 0.97 (0.44 – 2.13) 
*Propensity score model 1 (PS1) includes previous NRT use, enrollment time, 
Fagerstrom index, health, race, KIG intervention, age, sex, stress, hassles, and 
motivation to quit 
**Propensity score model 2 (PS2) includes previous NRT use, enrollment time, 
Fagerstrom index, health, race, KIG intervention, age, and sex 
 
  
 167 
Table 52. Effects of depression on 30-day PPA using two propensity score 
models 
 CES-D-10 
depression 
Physician-diagnosed 
depression 
Crude OR (95% CI) 1.91 (0.92 – 3.99) 1.23 (0.45 – 3.32) 
PS 1-adjusted OR* (95% CI) 2.13 (0.81 – 5.61) 1.14 (0.42 – 3.10) 
PS 2-adjusted OR** (95% CI) 2.01 (0.89 – 4.50) 1.20 (0.48 – 3.02) 
*Propensity score model 1 (PS1) includes previous NRT use, enrollment time, 
Fagerstrom index, health, race, KIG intervention, age, sex, stress, hassles, and 
motivation to quit 
**Propensity score model 2 (PS2) includes previous NRT use, enrollment time, 
Fagerstrom index, health, race, KIG intervention, age, and sex 
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Figure 7. Distribution of propensity scores for depressed and not depressed groups 
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Figure 8. DAG illustrating the relationship between depression and smoking abstinence where motivation to quit, 
hassles, and stress are on the causal pathway 
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CONCLUSION 
 The Kick it for Good study utilized a motivational interviewing-based TTA 
intervention to help smokers in public housing achieve abstinence from tobacco.  
This dissertation explored mediators and moderators of the intervention effect, 
predictors of attitudes and knowledge of nicotine replacement therapy, and the 
effect of depression on smoking abstinence, to further understand the 
determinants and mechanisms of cessation in a socioeconomically 
disadvantaged population.   
 We found no evidence of mediation of the intervention effect by NRT use 
or utilization of the Quitline or local clinic programs.  This suggests the TTA 
intervention itself and not uptake of the cessation resources offered by the TTA 
was the most impactful on helping smokers quit.  Furthermore, participants 
reported high satisfaction with their TTA in general and often wanted to continue 
talking with the TTA about smoking cessation.  These results support the use of 
community health workers to deliver interventions among socioeconomically 
disadvantaged populations as participants may be more likely to establish 
rapport with someone they view as a peer. 
 We found motivation to quit did not mediate the intervention effect, 
although self-efficacy to quit may have played a mediating role.  Baseline levels 
of motivation to quit were high in this sample so the lack of mediation may be due 
to a ceiling effect.  It could also be that motivation to quit is a dynamic state that 
was not properly captured in our study due to issues of temporality.  While this 
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issue similarly plagued our measurement of self-efficacy to quit, we did find 
potential mediation via this pathway.  Although our conclusions are limited due to 
the wide confidence interval of the indirect effect, there is literature to support 
that increasing smokers’ confidence can positively affect cessation outcomes.  
The TTA intervention also emphasized increasing self-efficacy to quit among 
intervention participants so this mediating pathway is plausible.  These results 
support the strong weight of research evidence showing that increasing smokers’ 
self-efficacy to abstain enhances abstinence outcomes. 
 The effect of the TTA intervention was greater among smokers who did 
not live with other smokers versus those who did.  Maintaining an environment 
that is conducive to quitting is essential for smokers to achieve abstinence from 
tobacco.  Our results suggest an integral part of this environment is to minimize 
contact with other smokers where possible.  Similarly, the effect of the TTA 
intervention was greater among smokers who reported low levels of perceived 
stress versus smokers who reported high levels of perceived stress.  In addition 
to the built environment, the psychosocial environment should be optimized in 
order to encourage abstinence from tobacco.  While there is inherent life stress 
associated with living in public housing, smokers should learn to manage their 
perceived stress as much as possible in order to quit smoking. 
 We did not find the intervention effect on cessation was moderated by 
age, gender, or race.  This is encouraging that the TTA intervention was similarly 
effective for all of these demographic groups.  We also did not find moderation by 
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nicotine dependence or social support, which may be due to the majority of our 
public housing sample reporting low nicotine dependence and high social support 
at baseline.  Notably, the moderation analyses suffered from vast imprecision 
and the conclusions from these results should be tempered with caution.  
Otherwise, we found minimal sources of bias from confounding, misclassification, 
or selection bias to impact our results.   
Predictors of attitudes and knowledge of nicotine replacement therapy 
were examined over the course of the study.  We found the TTA intervention did 
not impact aNRT and while the intervention was not aimed at increasing attitudes 
and knowledge of NRT directly, TTAs did discuss cessation methods and 
resources with participants.  The intervention effect may have waned over time or 
may only have been evident with increased contact with the TTA, although it is 
most likely that the intervention simply did not change smokers’ attitudes and 
knowledge of NRT.  There is well-documented evidence for the lack of trust and 
misinformation about pharmacotherapy aids among socioeconomically 
disadvantaged smokers and it could be these concerns were not addressed 
enough to warrant changes in aNRT. 
We found participants who discussed methods to quit smoking and 
discussed using NRT to quit smoking were more likely to have greater 
knowledge and more positive attitudes about NRT than those who did not 
discuss with their doctor.  Since physician advice is considered standard clinical 
practice to help smokers quit tobacco, these results echo previous studies on the 
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utility of physician engagement and support the use of this approach among 
socioeconomically disadvantaged populations. 
We found the effect of depression on smoking cessation to be dependent 
on the measure of depression although it was most reliable by the CES-D-10.  
Self-report of physician diagnosed depression was unassociated with smoking 
cessation while those with CES-D-10 depression were more likely to be abstinent 
from smoking than those without CES-D-10 depression.  While depression is 
thought to hinder smokers’ cessation efforts, our results suggest at minimum that 
depression does not impede smokers’ ability to achieve abstinence and at best 
suggests depressed smokers are more likely to quit than non-depressed 
smokers.  In either case, we can be confident that in the context of a cessation 
intervention socioeconomically disadvantaged smokers who suffer from 
depression are able to quit smoking at a similar rate as non-depressed smokers.  
We hypothesized that social support would buffer the negative effects of 
depression on smoking cessation.  First, we did not find depression to have 
adverse effects on cessation.  Second, we did not find social support to moderate 
the effect of CES-D-10 depression, but did find evidence of moderation by 
physician-diagnosed depression.  Among those with high social support the 
effect of depression was positive on cessation and among those with low social 
support the effect of depression was negative on cessation.  However, these 
analyses suffered from a lack of sufficient statistical power to detect a moderating 
effect and our conclusions should be met with caution.   
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To address the potential for misclassification of depression by the CES-D-
10, we varied the cutoff value for depression classification and observed changes 
in the effect of depression on cessation.  As the cutoff value was increased, the 
effect of depression was consistently closer to the null and even beyond the null 
for the highest cutoff values assessed.  This was surprising given our assumption 
of non-differential and independent measurement error and we expected the 
increased cutoff values to yield estimates further from the null.  While it could be 
that there is minimal misclassification error at the validated cutoff point of 10, we 
maintain the CES-D-10 is not specific enough to discriminate clinical depression 
among public housing residents.  Our conflicting results highlight the need for 
validation of the CES-D-10 in socioeconomically disadvantaged populations.    
A major limitation echoed throughout the dissertation studies was the lack 
of sufficient temporal resolution for study variables including motivation to quit, 
attitudes towards nicotine replacement therapy, and depression.  These dynamic 
psychosocial states may require more continuous monitoring than was available 
through the secondary use of the KIG data.  Increasing the temporal resolution of 
these variables may lend further evidence for the associated findings and we 
suggest the use of ecological momentary assessment in future studies.  Another 
major limitation was insufficient power to assess study effects throughout the 
dissertation.  While analytic methods including multiple imputation procedures 
showed robust results compared to the complete case analyses, future 
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intervention studies would ideally be able to recruit enough participants prior to 
data analysis.     
This research provides valuable information for researchers and clinicians 
to support efforts to address the disparity in smoking rates among 
socioeconomically disadvantaged populations.  Modifiable risk factors are the 
leading causes of mortality in the United States and tobacco is the primary 
culprit.  Despite the steady decrease in smoking prevalence in the general 
population, there remains a higher proportion of low-income and racial/ethnic 
minorities who continue to smoke cigarettes.  The preventable differences in the 
burden of tobacco use may be addressed by tailoring interventions to help 
socioeconomically disadvantaged smokers quit smoking.  This dissertation study 
provides a variety of recommendations to help achieve this goal, including 
increasing self-efficacy to quit, minimizing contact with other smokers, and 
engaging physicians to discuss smoking cessation methods.  
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